| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.685 | 0.005 | 0.685 | 5 Hydroxytryptamine release inhibitor | 0.449 0.052 DBMET01926 0.417 0.068 DBMET01927 0.549 0.02 DBMET01928 0.375 0.095 DBMET01929 0.501 0.032 DBMET01934 0.435 0.058 DBMET01935 0.36 0.107 DBMET01937 0.452 0.05 DBMET01942 0.431 0.06 DBMET01933 0.368 0.101 DBMET01936 0.342 0.122 DBMET01938 0.292 0.174 DBMET01939 0.36 0.107 DBMET01940 0.518 0.027 DBMET01941 | ||
| 0.634 | 0.015 | 0.634 | Aldehyde oxidase inhibitor | 0.148 0.141 DBMET01933 0.211 0.099 DBMET01938 | ||
| 0.546 | 0.003 | 0.546 | Succinate dehydrogenase inhibitor | 0.182 0.065 DBMET01926 0.221 0.035 DBMET01928 0.159 0.097 DBMET01929 0.168 0.083 DBMET01934 0.15 0.113 DBMET01935 0.173 0.076 DBMET01937 0.178 0.07 DBMET01942 0.158 0.098 DBMET01933 0.182 0.066 DBMET01938 0.151 0.111 DBMET01939 0.173 0.076 DBMET01940 0.228 0.031 DBMET01941 | ||
| 0.526 | 0.029 | 0.73 | Cholesterol antagonist | 0.666 0.011 DBMET01926 0.585 0.02 DBMET01927 0.588 0.02 DBMET01928 0.62 0.016 DBMET01929 0.626 0.015 DBMET01934 0.603 0.018 DBMET01935 0.73 0.006 DBMET01937 0.677 0.01 DBMET01942 0.283 0.102 DBMET01932 0.666 0.011 DBMET01933 0.358 0.061 DBMET01936 0.601 0.018 DBMET01938 0.689 0.009 DBMET01939 0.73 0.006 DBMET01940 0.712 0.007 DBMET01941 | DBMET01940 | |
| 0.504 | 0.032 | 0.504 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.469 | 0.008 | 0.611 | Non-steroidal antiinflammatory agent | 0.611 0.004 DBMET01926 0.403 0.013 DBMET01927 0.513 0.006 DBMET01928 0.482 0.007 DBMET01929 0.501 0.007 DBMET01934 0.565 0.005 DBMET01935 0.535 0.005 DBMET01937 0.61 0.004 DBMET01942 0.146 0.12 DBMET01932 0.482 0.007 DBMET01933 0.521 0.006 DBMET01936 0.415 0.012 DBMET01938 0.396 0.014 DBMET01939 0.535 0.005 DBMET01940 0.55 0.005 DBMET01941 | DBMET01926 | |
| 0.489 | 0.033 | 0.489 | Histamine release inhibitor | 0.225 0.176 DBMET01926 0.357 0.096 DBMET01928 0.216 0.185 DBMET01929 0.317 0.115 DBMET01934 0.205 0.196 DBMET01935 0.251 0.154 DBMET01942 0.36 0.095 DBMET01933 0.334 0.107 DBMET01941 | ||
| 0.411 | 0.003 | 0.411 | Electrolyte absorption antagonist | 0.107 0.049 DBMET01941 | ||
| 0.402 | 0.002 | 0.402 | Dihydroorotase inhibitor | |||
| 0.385 | 0.004 | 0.385 | Ferrochelatase inhibitor | |||
| 0.389 | 0.016 | 0.389 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.399 | 0.038 | 0.399 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.387 | 0.029 | 0.387 | Calcium channel activator | 0.271 0.123 DBMET01926 0.227 0.176 DBMET01935 0.239 0.161 DBMET01937 0.269 0.125 DBMET01942 0.296 0.096 DBMET01933 0.262 0.133 DBMET01936 0.239 0.161 DBMET01940 0.215 0.191 DBMET01941 | ||
| 0.352 | 0.004 | 0.352 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.173 0.021 DBMET01926 0.122 0.038 DBMET01927 0.165 0.023 DBMET01928 0.119 0.04 DBMET01929 0.233 0.011 DBMET01934 0.119 0.039 DBMET01935 0.252 0.009 DBMET01937 0.108 0.047 DBMET01942 0.106 0.049 DBMET01933 0.122 0.038 DBMET01938 0.179 0.019 DBMET01939 0.252 0.009 DBMET01940 0.254 0.009 DBMET01941 | ||
| 0.444 | 0.113 | 0.818 | Antiinflammatory | 0.814 0.013 DBMET01926 0.728 0.026 DBMET01927 0.764 0.02 DBMET01928 0.789 0.017 DBMET01929 0.752 0.022 DBMET01934 0.795 0.016 DBMET01935 0.788 0.017 DBMET01937 0.802 0.015 DBMET01942 0.49 0.092 DBMET01932 0.818 0.013 DBMET01933 0.779 0.018 DBMET01936 0.789 0.017 DBMET01938 0.76 0.021 DBMET01939 0.788 0.017 DBMET01940 0.786 0.017 DBMET01941 | DBMET01933 | |
| 0.329 | 0.013 | 0.393 | Alpha-N-acetylglucosaminidase inhibitor | 0.197 0.035 DBMET01926 0.101 0.1 DBMET01927 0.239 0.025 DBMET01928 0.133 0.066 DBMET01929 0.393 0.009 DBMET01934 0.117 0.08 DBMET01935 0.297 0.016 DBMET01937 0.104 0.096 DBMET01942 0.197 0.035 DBMET01933 0.212 0.031 DBMET01938 0.205 0.033 DBMET01939 0.297 0.016 DBMET01940 0.335 0.013 DBMET01941 | DBMET01934 | |
| 0.316 | 0.003 | 0.316 | Dihydroorotate dehydrogenase inhibitor | 0.047 0.041 DBMET01928 | ||
| 0.32 | 0.009 | 0.419 | Hexokinase inhibitor | 0.314 0.009 DBMET01926 0.354 0.006 DBMET01927 0.416 0.004 DBMET01928 0.256 0.016 DBMET01929 0.419 0.004 DBMET01934 0.277 0.013 DBMET01935 0.351 0.006 DBMET01937 0.319 0.009 DBMET01942 0.153 0.076 DBMET01932 0.358 0.005 DBMET01933 0.242 0.019 DBMET01936 0.247 0.018 DBMET01938 0.305 0.01 DBMET01939 0.351 0.006 DBMET01940 0.379 0.005 DBMET01941 | DBMET01934 | |
| 0.367 | 0.077 | 0.367 | GABA C receptor rho-3 antagonist | |||
| 0.38 | 0.095 | 0.402 | Calcium channel L-type activator | 0.244 0.212 DBMET01937 0.402 0.08 DBMET01933 0.279 0.175 DBMET01939 0.244 0.212 DBMET01940 | DBMET01933 | |
| 0.305 | 0.019 | 0.355 | Interferon gamma antagonist | 0.291 0.021 DBMET01926 0.308 0.019 DBMET01927 0.327 0.016 DBMET01928 0.251 0.028 DBMET01929 0.313 0.018 DBMET01934 0.301 0.02 DBMET01935 0.28 0.023 DBMET01937 0.32 0.017 DBMET01942 0.174 0.054 DBMET01932 0.337 0.015 DBMET01933 0.355 0.014 DBMET01936 0.338 0.015 DBMET01938 0.238 0.031 DBMET01939 0.28 0.023 DBMET01940 0.307 0.019 DBMET01941 | DBMET01936 | |
| 0.279 | 0.004 | 0.279 | Prostaglandin-E synthase inhibitor | |||
| 0.293 | 0.024 | 0.293 | Diuretic | 0.153 0.075 DBMET01926 0.217 0.038 DBMET01928 0.158 0.07 DBMET01934 0.119 0.106 DBMET01942 0.175 0.057 DBMET01936 0.181 0.053 DBMET01941 | ||
| 0.326 | 0.066 | 0.326 | 12-Lipoxygenase inhibitor | 0.208 0.143 DBMET01942 | ||
| 0.292 | 0.039 | 0.292 | Gastrin inhibitor | |||
| 0.374 | 0.125 | 0.905 | Alpha-glucosidase inhibitor | 0.839 0.013 DBMET01926 0.677 0.038 DBMET01927 0.732 0.028 DBMET01928 0.824 0.015 DBMET01929 0.527 0.073 DBMET01934 0.873 0.01 DBMET01935 0.751 0.025 DBMET01937 0.9 0.007 DBMET01942 0.6 0.054 DBMET01932 0.905 0.007 DBMET01933 0.803 0.018 DBMET01936 0.838 0.014 DBMET01938 0.731 0.028 DBMET01939 0.751 0.025 DBMET01940 0.693 0.035 DBMET01941 | DBMET01933 | |
| 0.256 | 0.007 | 0.256 | Potassium channel (Ca-activated) activator | 0.101 0.055 DBMET01941 | ||
| 0.279 | 0.042 | 0.279 | MAP kinase kinase 2 inhibitor | |||
| 0.273 | 0.041 | 0.563 | Anesthetic general | 0.434 0.013 DBMET01926 0.314 0.03 DBMET01927 0.325 0.028 DBMET01928 0.386 0.018 DBMET01929 0.342 0.025 DBMET01934 0.375 0.02 DBMET01935 0.412 0.015 DBMET01937 0.419 0.014 DBMET01942 0.164 0.099 DBMET01932 0.524 0.006 DBMET01933 0.369 0.021 DBMET01936 0.563 0.005 DBMET01938 0.365 0.021 DBMET01939 0.412 0.015 DBMET01940 0.399 0.016 DBMET01941 | DBMET01938 | |
| 0.262 | 0.032 | 0.262 | Mcl-1 antagonist | 0.167 0.076 DBMET01928 0.19 0.061 DBMET01929 0.206 0.052 DBMET01934 0.138 0.102 DBMET01942 0.124 0.12 DBMET01933 0.137 0.103 DBMET01938 0.138 0.102 DBMET01939 0.134 0.106 DBMET01941 | ||
| 0.236 | 0.006 | 0.236 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.24 | 0.014 | 0.302 | Mannose-6-phosphate isomerase inhibitor | 0.257 0.01 DBMET01926 0.302 0.005 DBMET01927 0.251 0.012 DBMET01928 0.23 0.018 DBMET01929 0.282 0.007 DBMET01934 0.264 0.009 DBMET01935 0.265 0.009 DBMET01937 0.244 0.013 DBMET01942 0.177 0.044 DBMET01932 0.281 0.007 DBMET01933 0.149 0.066 DBMET01936 0.278 0.007 DBMET01938 0.237 0.015 DBMET01939 0.265 0.009 DBMET01940 0.256 0.011 DBMET01941 | DBMET01927 | |
| 0.281 | 0.058 | 0.281 | Superoxide dismutase inhibitor | |||
| 0.234 | 0.011 | 0.443 | Cyclooxygenase 3 inhibitor | 0.349 0.005 DBMET01926 0.326 0.005 DBMET01927 0.443 0.004 DBMET01928 0.319 0.005 DBMET01929 0.338 0.005 DBMET01934 0.277 0.007 DBMET01935 0.332 0.005 DBMET01937 0.391 0.004 DBMET01942 0.2 0.019 DBMET01932 0.384 0.004 DBMET01933 0.388 0.004 DBMET01936 0.261 0.008 DBMET01938 0.303 0.006 DBMET01939 0.332 0.005 DBMET01940 0.379 0.004 DBMET01941 | DBMET01928 | |
| 0.232 | 0.009 | 0.232 | Porphobilinogen synthase inhibitor | |||
| 0.3 | 0.079 | 0.3 | Streptokinase A inhibitor | |||
| 0.238 | 0.022 | 0.313 | Insulin secretagoues | 0.272 0.016 DBMET01926 0.124 0.104 DBMET01927 0.281 0.015 DBMET01928 0.274 0.016 DBMET01929 0.207 0.032 DBMET01934 0.239 0.022 DBMET01935 0.253 0.019 DBMET01937 0.266 0.017 DBMET01942 0.313 0.011 DBMET01933 0.184 0.045 DBMET01936 0.211 0.031 DBMET01938 0.256 0.018 DBMET01939 0.253 0.019 DBMET01940 0.304 0.012 DBMET01941 | DBMET01933 | |
| 0.237 | 0.023 | 0.237 | M17 leucyl aminopeptidase inhibitor | |||
| 0.24 | 0.03 | 0.24 | Heat shock protein 90 alpha antagonist | |||
| 0.254 | 0.045 | 0.254 | DNA methyltransferase I inhibitor | 0.196 0.071 DBMET01928 0.161 0.093 DBMET01933 0.141 0.114 DBMET01941 | ||
| 0.227 | 0.019 | 0.227 | Cystathionine beta-synthase inhibitor | 0.096 0.082 DBMET01926 0.115 0.062 DBMET01927 0.211 0.022 DBMET01928 0.114 0.063 DBMET01929 0.103 0.073 DBMET01934 0.094 0.085 DBMET01935 0.153 0.039 DBMET01942 0.142 0.044 DBMET01933 0.118 0.06 DBMET01941 | ||
| 0.221 | 0.016 | 0.449 | UDP-glucose 4-epimerase inhibitor | 0.323 0.009 DBMET01926 0.269 0.012 DBMET01927 0.396 0.006 DBMET01928 0.312 0.01 DBMET01929 0.449 0.004 DBMET01934 0.324 0.009 DBMET01935 0.398 0.006 DBMET01937 0.251 0.013 DBMET01942 0.138 0.033 DBMET01932 0.353 0.008 DBMET01933 0.175 0.022 DBMET01936 0.318 0.009 DBMET01938 0.391 0.006 DBMET01939 0.398 0.006 DBMET01940 0.406 0.005 DBMET01941 | DBMET01934 | |
| 0.213 | 0.009 | 0.283 | Triose-phosphate isomerase inhibitor | 0.126 0.029 DBMET01926 0.182 0.013 DBMET01928 0.111 0.038 DBMET01929 0.283 0.005 DBMET01934 0.092 0.058 DBMET01935 0.16 0.017 DBMET01937 0.092 0.057 DBMET01942 0.165 0.016 DBMET01933 0.118 0.033 DBMET01938 0.14 0.023 DBMET01939 0.16 0.017 DBMET01940 0.181 0.013 DBMET01941 | DBMET01934 | |
| 0.219 | 0.018 | 0.219 | Arachidonic acid antagonist | 0.181 0.053 DBMET01926 0.133 0.109 DBMET01927 0.181 0.052 DBMET01928 0.176 0.058 DBMET01929 0.153 0.084 DBMET01934 0.147 0.092 DBMET01935 0.158 0.079 DBMET01937 0.176 0.058 DBMET01942 0.126 0.118 DBMET01932 0.183 0.05 DBMET01933 0.155 0.082 DBMET01938 0.152 0.086 DBMET01939 0.158 0.079 DBMET01940 0.176 0.058 DBMET01941 | ||
| 0.342 | 0.141 | 0.342 | DNA directed DNA polymerase inhibitor | 0.271 0.179 DBMET01926 0.253 0.189 DBMET01935 0.298 0.162 DBMET01942 0.29 0.167 DBMET01933 0.293 0.165 DBMET01938 | ||
| 0.218 | 0.017 | 0.218 | GABA C receptor agonist | |||
| 0.214 | 0.016 | 0.214 | Carbonic anhydrase XV inhibitor | |||
| 0.207 | 0.009 | 0.207 | Creatine kinase inhibitor | |||
| 0.221 | 0.024 | 0.326 | ATPase inhibitor | 0.219 0.024 DBMET01926 0.242 0.015 DBMET01927 0.214 0.027 DBMET01928 0.164 0.079 DBMET01929 0.25 0.014 DBMET01934 0.199 0.038 DBMET01935 0.173 0.066 DBMET01937 0.222 0.023 DBMET01942 0.194 0.042 DBMET01933 0.326 0.005 DBMET01936 0.165 0.078 DBMET01938 0.173 0.066 DBMET01940 0.198 0.039 DBMET01941 | DBMET01936 | |
| 0.2 | 0.005 | 0.2 | NMDA receptor agonist | |||
| 0.206 | 0.011 | 0.206 | Interleukin 8 antagonist | 0.127 0.053 DBMET01938 | ||
| 0.236 | 0.043 | 0.304 | Nitric-oxide synthase stimulant | 0.246 0.035 DBMET01926 0.304 0.01 DBMET01927 0.247 0.034 DBMET01928 0.212 0.07 DBMET01929 0.185 0.117 DBMET01934 0.258 0.027 DBMET01935 0.268 0.022 DBMET01937 0.256 0.028 DBMET01942 0.19 0.107 DBMET01932 0.233 0.046 DBMET01933 0.217 0.064 DBMET01936 0.206 0.079 DBMET01938 0.232 0.047 DBMET01939 0.268 0.022 DBMET01940 0.219 0.061 DBMET01941 | DBMET01927 | |
| 0.222 | 0.032 | 0.222 | Phospholipase A2 inhibitor | 0.126 0.107 DBMET01926 0.125 0.109 DBMET01928 0.121 0.115 DBMET01935 0.132 0.098 DBMET01942 0.134 0.094 DBMET01933 0.133 0.096 DBMET01938 0.139 0.086 DBMET01941 | ||
| 0.185 | 0.007 | 0.185 | Biliverdin reductase inhibitor | 0.068 0.033 DBMET01934 | ||
| 0.203 | 0.027 | 0.297 | Aldehyde dehydrogenase inhibitor | 0.136 0.057 DBMET01926 0.113 0.079 DBMET01927 0.181 0.033 DBMET01928 0.101 0.097 DBMET01929 0.133 0.059 DBMET01934 0.141 0.053 DBMET01935 0.16 0.042 DBMET01937 0.157 0.043 DBMET01942 0.154 0.045 DBMET01933 0.297 0.012 DBMET01938 0.119 0.072 DBMET01939 0.16 0.042 DBMET01940 0.164 0.04 DBMET01941 | DBMET01938 | |
| 0.235 | 0.06 | 0.277 | RNA-directed DNA polymerase inhibitor | 0.21 0.085 DBMET01926 0.277 0.037 DBMET01927 0.2 0.099 DBMET01928 0.225 0.068 DBMET01934 0.186 0.121 DBMET01935 0.221 0.073 DBMET01937 0.206 0.091 DBMET01942 0.207 0.09 DBMET01933 0.172 0.148 DBMET01938 0.174 0.144 DBMET01939 0.221 0.073 DBMET01940 0.199 0.101 DBMET01941 | DBMET01927 | |
| 0.228 | 0.053 | 0.228 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.182 0.091 DBMET01933 | ||
| 0.181 | 0.007 | 0.181 | Ca2+-transporting ATPase inhibitor | 0.164 0.018 DBMET01926 0.149 0.044 DBMET01927 0.158 0.026 DBMET01928 0.148 0.047 DBMET01929 0.164 0.018 DBMET01934 0.149 0.044 DBMET01935 0.151 0.039 DBMET01937 0.151 0.04 DBMET01942 0.152 0.038 DBMET01933 0.133 0.104 DBMET01936 0.146 0.052 DBMET01938 0.136 0.089 DBMET01939 0.151 0.039 DBMET01940 0.166 0.016 DBMET01941 | ||
| 0.323 | 0.153 | 0.323 | DNA polymerase beta inhibitor | |||
| 0.198 | 0.029 | 0.198 | MAP kinase kinase inhibitor | |||
| 0.188 | 0.021 | 0.188 | Protein kinase (CK2) inhibitor | |||
| 0.174 | 0.009 | 0.174 | MAP kinase kinase 1 inhibitor | |||
| 0.169 | 0.004 | 0.169 | NMDA receptor glycine site agonist | |||
| 0.227 | 0.062 | 0.227 | DNA methylase inhibitor | 0.189 0.086 DBMET01928 0.194 0.083 DBMET01933 0.142 0.125 DBMET01938 0.174 0.098 DBMET01941 | ||
| 0.171 | 0.007 | 0.171 | Prostaglandin E2 antagonist | |||
| 0.17 | 0.008 | 0.17 | CC chemokine 6 receptor antagonist | 0.139 0.043 DBMET01926 0.133 0.061 DBMET01927 0.148 0.025 DBMET01928 0.137 0.048 DBMET01929 0.144 0.031 DBMET01934 0.132 0.062 DBMET01935 0.133 0.061 DBMET01937 0.135 0.053 DBMET01942 0.124 0.097 DBMET01932 0.135 0.054 DBMET01933 0.124 0.096 DBMET01936 0.133 0.059 DBMET01938 0.131 0.066 DBMET01939 0.133 0.061 DBMET01940 0.145 0.03 DBMET01941 | ||
| 0.173 | 0.013 | 0.385 | NADH dehydrogenase inhibitor | 0.262 0.007 DBMET01926 0.157 0.016 DBMET01927 0.254 0.008 DBMET01928 0.223 0.009 DBMET01929 0.359 0.005 DBMET01934 0.183 0.012 DBMET01935 0.351 0.005 DBMET01937 0.198 0.011 DBMET01942 0.139 0.02 DBMET01932 0.227 0.009 DBMET01933 0.09 0.056 DBMET01936 0.204 0.01 DBMET01938 0.297 0.007 DBMET01939 0.351 0.005 DBMET01940 0.385 0.005 DBMET01941 | DBMET01941 | |
| 0.241 | 0.086 | 0.354 | Interleukin agonist | 0.278 0.06 DBMET01926 0.159 0.158 DBMET01927 0.283 0.057 DBMET01928 0.247 0.081 DBMET01929 0.312 0.042 DBMET01934 0.206 0.115 DBMET01935 0.354 0.028 DBMET01937 0.268 0.066 DBMET01942 0.334 0.034 DBMET01933 0.184 0.135 DBMET01936 0.206 0.115 DBMET01938 0.322 0.038 DBMET01939 0.354 0.028 DBMET01940 0.309 0.044 DBMET01941 | DBMET01940 | |
| 0.181 | 0.029 | 0.181 | Protein kinase (CK2) alpha inhibitor | |||
| 0.186 | 0.04 | 0.222 | Cyclooxygenase 1 inhibitor | 0.188 0.04 DBMET01926 0.127 0.074 DBMET01927 0.158 0.052 DBMET01928 0.161 0.051 DBMET01929 0.141 0.062 DBMET01934 0.187 0.04 DBMET01935 0.156 0.054 DBMET01937 0.197 0.035 DBMET01942 0.222 0.027 DBMET01932 0.191 0.038 DBMET01933 0.126 0.074 DBMET01936 0.15 0.057 DBMET01938 0.133 0.068 DBMET01939 0.156 0.054 DBMET01940 0.17 0.048 DBMET01941 | DBMET01932 | |
| 0.245 | 0.101 | 0.245 | Insulysin inhibitor | |||
| 0.174 | 0.032 | 0.174 | Farnesoid X receptor antagonist | 0.12 0.105 DBMET01926 0.138 0.068 DBMET01935 0.116 0.115 DBMET01937 0.144 0.059 DBMET01942 0.135 0.073 DBMET01933 0.119 0.106 DBMET01936 0.116 0.115 DBMET01940 0.124 0.094 DBMET01941 | ||
| 0.159 | 0.018 | 0.159 | Histidine decarboxylase inhibitor | |||
| 0.153 | 0.014 | 0.153 | Keratolytic | 0.098 0.031 DBMET01933 | ||
| 0.174 | 0.038 | 0.174 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.142 | 0.008 | 0.142 | Purinergic P2X1 antagonist | 0.06 0.043 DBMET01934 0.058 0.046 DBMET01933 0.095 0.018 DBMET01938 0.065 0.036 DBMET01941 | ||
| 0.168 | 0.036 | 0.168 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.14 | 0.008 | 0.375 | Phosphorylase inhibitor | 0.234 0.004 DBMET01926 0.14 0.008 DBMET01927 0.134 0.009 DBMET01928 0.12 0.01 DBMET01929 0.19 0.005 DBMET01934 0.197 0.005 DBMET01935 0.358 0.003 DBMET01937 0.222 0.004 DBMET01942 0.195 0.005 DBMET01933 0.154 0.007 DBMET01936 0.375 0.003 DBMET01938 0.201 0.005 DBMET01939 0.358 0.003 DBMET01940 0.336 0.003 DBMET01941 | DBMET01938 | |
| 0.158 | 0.027 | 0.158 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.195 | 0.063 | 0.195 | Dual specificity phosphatase 3 inhibitor | |||
| 0.268 | 0.137 | 0.268 | Calpain 2 inhibitor | |||
| 0.222 | 0.091 | 0.222 | Aryl hydrocarbon receptor agonist | 0.19 0.108 DBMET01938 | ||
| 0.159 | 0.029 | 0.159 | Heat shock protein 70 antagonist | 0.136 0.092 DBMET01928 0.135 0.097 DBMET01933 | ||
| 0.236 | 0.109 | 0.236 | Lipoxygenase inhibitor | |||
| 0.17 | 0.043 | 0.17 | MAP kinase 3 inhibitor | 0.126 0.118 DBMET01937 0.126 0.118 DBMET01940 | ||
| 0.19 | 0.064 | 0.19 | Amyloid beta precursor protein antagonist | |||
| 0.138 | 0.012 | 0.138 | Alcohol oxidase inhibitor | |||
| 0.163 | 0.038 | 0.163 | Cathepsin H inhibitor | |||
| 0.154 | 0.028 | 0.154 | TRPA1 agonist | 0.098 0.092 DBMET01942 0.124 0.054 DBMET01933 0.118 0.061 DBMET01938 | ||
| 0.22 | 0.095 | 0.385 | DNA synthesis inhibitor | 0.32 0.037 DBMET01926 0.224 0.09 DBMET01927 0.325 0.036 DBMET01928 0.32 0.037 DBMET01929 0.353 0.03 DBMET01934 0.303 0.043 DBMET01935 0.385 0.024 DBMET01937 0.291 0.047 DBMET01942 0.351 0.03 DBMET01933 0.219 0.096 DBMET01936 0.37 0.026 DBMET01938 0.385 0.024 DBMET01939 0.385 0.024 DBMET01940 0.373 0.026 DBMET01941 | DBMET01940 | |
| 0.158 | 0.035 | 0.158 | Interleukin 1b antagonist | 0.123 0.06 DBMET01926 0.156 0.036 DBMET01927 0.111 0.07 DBMET01937 0.112 0.069 DBMET01942 0.139 0.048 DBMET01933 0.13 0.055 DBMET01938 0.111 0.07 DBMET01940 0.118 0.064 DBMET01941 | ||
| 0.168 | 0.045 | 0.168 | NADPH oxidase inhibitor | |||
| 0.132 | 0.009 | 0.132 | D-Ala-D-Ala ligase inhibitor | |||
| 0.147 | 0.027 | 0.147 | Adenylate kinase inhibitor | 0.098 0.071 DBMET01941 | ||
| 0.121 | 0.002 | 0.121 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.03 DBMET01928 0.047 0.018 DBMET01941 | ||
| 0.128 | 0.009 | 0.128 | CDC25B inhibitor | 0.062 0.048 DBMET01926 0.059 0.053 DBMET01928 0.057 0.055 DBMET01929 0.067 0.041 DBMET01935 0.065 0.044 DBMET01937 0.068 0.04 DBMET01942 0.071 0.037 DBMET01933 0.075 0.033 DBMET01938 0.06 0.05 DBMET01939 0.065 0.044 DBMET01940 0.073 0.035 DBMET01941 | ||
| 0.199 | 0.081 | 0.199 | Pyruvate kinase inhibitor | 0.14 0.125 DBMET01935 0.159 0.108 DBMET01942 0.152 0.113 DBMET01933 | ||
| 0.13 | 0.012 | 0.13 | GABA aminotransferase inhibitor | 0.083 0.042 DBMET01928 0.072 0.059 DBMET01934 0.072 0.058 DBMET01942 0.097 0.03 DBMET01933 0.115 0.018 DBMET01938 0.092 0.033 DBMET01941 | ||
| 0.148 | 0.031 | 0.148 | EphA2 antagonist | |||
| 0.143 | 0.026 | 0.143 | NMDA receptor antagonist | |||
| 0.181 | 0.065 | 0.181 | Peroxidase inhibitor | |||
| 0.192 | 0.079 | 0.192 | Death-associated protein kinase 3 inhibitor | |||
| 0.14 | 0.028 | 0.14 | Catalase inhibitor | |||
| 0.159 | 0.048 | 0.159 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.122 | 0.011 | 0.122 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.057 0.043 DBMET01928 0.07 0.031 DBMET01942 0.07 0.031 DBMET01933 0.063 0.036 DBMET01941 | ||
| 0.142 | 0.032 | 0.142 | Carbonic anhydrase III inhibitor | 0.105 0.057 DBMET01933 | ||
| 0.13 | 0.02 | 0.13 | Glutamate dehydrogenase inhibitor | |||
| 0.118 | 0.009 | 0.118 | NMDA receptor subunit 3B antagonist | |||
| 0.161 | 0.053 | 0.161 | Alkaline phosphatase inhibitor | 0.119 0.088 DBMET01927 | ||
| 0.199 | 0.09 | 0.199 | ErbB-1 antagonist | |||
| 0.216 | 0.108 | 0.216 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.123 | 0.016 | 0.123 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.124 | 0.017 | 0.124 | Bile acid receptor antagonist | 0.087 0.081 DBMET01926 0.093 0.065 DBMET01935 0.096 0.059 DBMET01942 0.092 0.068 DBMET01933 0.095 0.062 DBMET01941 | ||
| 0.146 | 0.039 | 0.146 | Aminopeptidase B inhibitor | |||
| 0.136 | 0.029 | 0.169 | Uric acid excretion stimulant | 0.112 0.043 DBMET01926 0.129 0.033 DBMET01928 0.105 0.048 DBMET01929 0.085 0.073 DBMET01934 0.102 0.051 DBMET01935 0.13 0.032 DBMET01937 0.12 0.038 DBMET01942 0.126 0.034 DBMET01933 0.125 0.035 DBMET01938 0.123 0.036 DBMET01939 0.13 0.032 DBMET01940 0.169 0.018 DBMET01941 | DBMET01941 | |
| 0.161 | 0.055 | 0.206 | Cell wall synthesis inhibitor | 0.16 0.057 DBMET01926 0.17 0.048 DBMET01928 0.178 0.041 DBMET01929 0.171 0.047 DBMET01934 0.14 0.075 DBMET01935 0.183 0.038 DBMET01937 0.151 0.065 DBMET01942 0.149 0.067 DBMET01933 0.112 0.111 DBMET01938 0.206 0.028 DBMET01939 0.183 0.038 DBMET01940 0.202 0.029 DBMET01941 | DBMET01939 | |
| 0.111 | 0.004 | 0.111 | Dihydroorotate oxidase inhibitor | |||
| 0.165 | 0.059 | 0.165 | Cyclooxygenase inhibitor | 0.152 0.068 DBMET01926 0.142 0.077 DBMET01928 0.147 0.072 DBMET01929 0.12 0.099 DBMET01934 0.145 0.074 DBMET01935 0.124 0.094 DBMET01937 0.157 0.064 DBMET01942 0.146 0.073 DBMET01932 0.144 0.075 DBMET01933 0.141 0.078 DBMET01938 0.121 0.097 DBMET01939 0.124 0.094 DBMET01940 0.131 0.087 DBMET01941 | ||
| 0.174 | 0.068 | 0.179 | Phospholipase C inhibitor | 0.154 0.098 DBMET01928 0.153 0.1 DBMET01934 0.139 0.13 DBMET01935 0.145 0.117 DBMET01937 0.138 0.133 DBMET01942 0.163 0.083 DBMET01933 0.179 0.062 DBMET01938 0.145 0.117 DBMET01940 0.151 0.105 DBMET01941 | DBMET01938 | |
| 0.17 | 0.065 | 0.17 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.168 | 0.064 | 0.251 | Protein-tyrosine phosphatase inhibitor | 0.126 0.106 DBMET01926 0.127 0.104 DBMET01928 0.165 0.066 DBMET01929 0.136 0.094 DBMET01935 0.133 0.097 DBMET01937 0.143 0.086 DBMET01942 0.251 0.031 DBMET01932 0.16 0.069 DBMET01933 0.151 0.077 DBMET01938 0.17 0.062 DBMET01939 0.133 0.097 DBMET01940 0.173 0.061 DBMET01941 | DBMET01932 | |
| 0.111 | 0.007 | 0.111 | Glutamate (mGluR6) antagonist | |||
| 0.243 | 0.141 | 0.378 | Vasodilator, coronary | 0.274 0.11 DBMET01926 0.262 0.122 DBMET01928 0.254 0.13 DBMET01929 0.246 0.139 DBMET01934 0.23 0.154 DBMET01935 0.309 0.08 DBMET01937 0.287 0.098 DBMET01942 0.378 0.043 DBMET01933 0.221 0.162 DBMET01938 0.29 0.096 DBMET01939 0.309 0.08 DBMET01940 0.271 0.114 DBMET01941 | DBMET01933 | |
| 0.135 | 0.033 | 0.546 | Beta glucuronidase inhibitor | 0.365 0.004 DBMET01926 0.221 0.01 DBMET01927 0.296 0.006 DBMET01928 0.391 0.004 DBMET01929 0.131 0.037 DBMET01934 0.36 0.005 DBMET01935 0.277 0.007 DBMET01937 0.502 0.003 DBMET01942 0.14 0.03 DBMET01932 0.514 0.003 DBMET01933 0.193 0.014 DBMET01936 0.546 0.003 DBMET01938 0.297 0.006 DBMET01939 0.277 0.007 DBMET01940 0.324 0.005 DBMET01941 | DBMET01938 | |
| 0.162 | 0.06 | 0.162 | Thiol protease inhibitor | |||
| 0.173 | 0.071 | 0.173 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.109 | 0.007 | 0.109 | Nicotinic acid receptor 1 agonist | |||
| 0.17 | 0.069 | 0.17 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.125 | 0.028 | 0.125 | Carbonic anhydrase XIII inhibitor | 0.101 0.038 DBMET01928 0.085 0.046 DBMET01933 | ||
| 0.131 | 0.035 | 0.131 | Urease inhibitor | |||
| 0.131 | 0.034 | 0.131 | DOPA decarboxylase inhibitor | |||
| 0.158 | 0.063 | 0.433 | Protein kinase stimulant | 0.267 0.022 DBMET01926 0.229 0.032 DBMET01927 0.312 0.015 DBMET01928 0.252 0.026 DBMET01929 0.3 0.017 DBMET01934 0.252 0.026 DBMET01935 0.37 0.01 DBMET01937 0.306 0.016 DBMET01942 0.156 0.064 DBMET01932 0.433 0.006 DBMET01933 0.282 0.019 DBMET01936 0.335 0.013 DBMET01938 0.347 0.012 DBMET01939 0.37 0.01 DBMET01940 0.239 0.029 DBMET01941 | DBMET01933 | |
| 0.101 | 0.008 | 0.101 | NMDA receptor subunit 3A antagonist | |||
| 0.096 | 0.004 | 0.096 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.097 | 0.006 | 0.097 | Nicotinic acid receptor 2 agonist | |||
| 0.168 | 0.077 | 0.168 | Dual specificity phosphatase inhibitor | |||
| 0.095 | 0.004 | 0.095 | NMDA receptor glycine site antagonist | |||
| 0.095 | 0.005 | 0.158 | Adenine nucleotide translocase inhibitor | 0.13 0.003 DBMET01926 0.086 0.007 DBMET01927 0.133 0.003 DBMET01928 0.127 0.003 DBMET01929 0.106 0.004 DBMET01934 0.128 0.003 DBMET01935 0.127 0.003 DBMET01937 0.126 0.004 DBMET01942 0.095 0.005 DBMET01932 0.143 0.003 DBMET01933 0.093 0.005 DBMET01936 0.117 0.004 DBMET01938 0.125 0.004 DBMET01939 0.127 0.003 DBMET01940 0.158 0.003 DBMET01941 | DBMET01941 | |
| 0.228 | 0.138 | 0.228 | Thyroid hormone antagonist | |||
| 0.12 | 0.032 | 0.12 | Potassium channel activator | |||
| 0.123 | 0.035 | 0.155 | Protein kinase C delta inhibitor | 0.122 0.036 DBMET01926 0.106 0.047 DBMET01929 0.118 0.038 DBMET01935 0.129 0.032 DBMET01937 0.124 0.034 DBMET01942 0.155 0.019 DBMET01933 0.081 0.075 DBMET01936 0.091 0.061 DBMET01938 0.113 0.042 DBMET01939 0.129 0.032 DBMET01940 0.124 0.034 DBMET01941 | DBMET01933 | |
| 0.092 | 0.005 | 0.092 | Nicotinic acid receptor agonist | |||
| 0.116 | 0.031 | 0.116 | Carbonic anhydrase VI inhibitor | 0.073 0.067 DBMET01937 0.071 0.07 DBMET01942 0.113 0.032 DBMET01933 0.077 0.062 DBMET01939 0.073 0.067 DBMET01940 | ||
| 0.139 | 0.057 | 0.139 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.114 | 0.031 | 0.114 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.09 | 0.008 | 0.09 | Kainate receptor antagonist | |||
| 0.108 | 0.027 | 0.108 | Myeloperoxidase inhibitor | |||
| 0.103 | 0.023 | 0.103 | Potassium channel large-conductance Ca-activated activator | 0.06 0.059 DBMET01941 | ||
| 0.152 | 0.073 | 0.292 | Heat shock protein 90 antagonist | 0.17 0.056 DBMET01926 0.22 0.03 DBMET01928 0.292 0.011 DBMET01929 0.25 0.021 DBMET01935 0.203 0.036 DBMET01942 0.191 0.042 DBMET01933 0.213 0.032 DBMET01936 0.154 0.07 DBMET01938 0.162 0.063 DBMET01939 | DBMET01929 | |
| 0.219 | 0.139 | 0.219 | Thyroid hormone beta antagonist | |||
| 0.105 | 0.027 | 0.105 | Glutamate decarboxylase inhibitor | |||
| 0.119 | 0.041 | 0.119 | GABA C receptor rho-1 antagonist | |||
| 0.095 | 0.018 | 0.095 | Potassium channel (ATP-sensitive) blocker | |||
| 0.151 | 0.074 | 0.151 | Cytidine deaminase inhibitor | |||
| 0.258 | 0.181 | 0.258 | Transcription factor inhibitor | |||
| 0.095 | 0.018 | 0.095 | Prostaglandin antagonist | |||
| 0.124 | 0.049 | 0.124 | GABA C receptor antagonist | |||
| 0.142 | 0.068 | 0.532 | Amylase inhibitor | 0.397 0.009 DBMET01926 0.425 0.008 DBMET01927 0.396 0.009 DBMET01928 0.356 0.012 DBMET01929 0.367 0.011 DBMET01934 0.366 0.012 DBMET01935 0.532 0.005 DBMET01937 0.495 0.006 DBMET01942 0.25 0.028 DBMET01932 0.514 0.005 DBMET01933 0.349 0.013 DBMET01936 0.323 0.016 DBMET01938 0.486 0.006 DBMET01939 0.532 0.005 DBMET01940 0.387 0.01 DBMET01941 | DBMET01940 | |
| 0.092 | 0.021 | 0.092 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.09 | 0.02 | 0.09 | NMDA 2C receptor antagonist | |||
| 0.093 | 0.023 | 0.093 | GABA B receptor agonist | |||
| 0.091 | 0.022 | 0.091 | Argininosuccinate synthase inhibitor | |||
| 0.276 | 0.207 | 0.276 | MAP kinase 1 inhibitor | |||
| 0.181 | 0.113 | 0.486 | Antiamyloidogenic | 0.269 0.063 DBMET01926 0.246 0.073 DBMET01928 0.304 0.05 DBMET01929 0.158 0.137 DBMET01934 0.365 0.036 DBMET01935 0.265 0.065 DBMET01937 0.359 0.037 DBMET01942 0.486 0.017 DBMET01933 0.162 0.132 DBMET01936 0.294 0.053 DBMET01938 0.299 0.052 DBMET01939 0.265 0.065 DBMET01940 0.315 0.047 DBMET01941 | DBMET01933 | |
| 0.077 | 0.009 | 0.077 | Leukotriene C antagonist | |||
| 0.109 | 0.043 | 0.109 | Alcohol dehydrogenase inhibitor | |||
| 0.145 | 0.08 | 0.145 | GABA C receptor rho-2 antagonist | |||
| 0.218 | 0.152 | 0.658 | Transcription factor NF kappa B inhibitor | 0.487 0.046 DBMET01926 0.448 0.053 DBMET01927 0.38 0.068 DBMET01928 0.509 0.043 DBMET01929 0.451 0.053 DBMET01934 0.522 0.041 DBMET01935 0.515 0.042 DBMET01937 0.583 0.033 DBMET01942 0.658 0.025 DBMET01933 0.566 0.036 DBMET01936 0.607 0.03 DBMET01938 0.537 0.039 DBMET01939 0.515 0.042 DBMET01940 0.471 0.049 DBMET01941 | DBMET01933 | |
| 0.092 | 0.027 | 0.092 | Glycine receptor agonist | |||
| 0.22 | 0.157 | 0.461 | Interleukin 2 agonist | 0.406 0.025 DBMET01926 0.375 0.035 DBMET01927 0.335 0.053 DBMET01928 0.392 0.03 DBMET01929 0.39 0.03 DBMET01934 0.389 0.031 DBMET01935 0.461 0.013 DBMET01937 0.402 0.027 DBMET01942 0.352 0.045 DBMET01932 0.425 0.021 DBMET01933 0.331 0.055 DBMET01936 0.386 0.032 DBMET01938 0.446 0.016 DBMET01939 0.461 0.013 DBMET01940 0.413 0.024 DBMET01941 | DBMET01940 | |
| 0.106 | 0.043 | 0.106 | ABCA1 expression enhancer | 0.092 0.061 DBMET01934 | ||
| 0.077 | 0.015 | 0.077 | Aconitate hydratase inhibitor | |||
| 0.115 | 0.053 | 0.115 | Interleukin 2 antagonist | |||
| 0.133 | 0.072 | 0.149 | Interleukin 1 antagonist | 0.149 0.058 DBMET01927 0.112 0.102 DBMET01933 0.111 0.103 DBMET01938 | DBMET01927 | |
| 0.074 | 0.012 | 0.074 | Cathepsin L2 inhibitor | |||
| 0.103 | 0.043 | 0.103 | Histamine N-methyltransferase inhibitor | |||
| 0.147 | 0.088 | 0.147 | Polo-like kinase-3 inhibitor | |||
| 0.071 | 0.013 | 0.071 | Pregnane X receptor antagonist | |||
| 0.164 | 0.107 | 0.164 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.07 | 0.013 | 0.07 | CXC chemokine 1 receptor antagonist | |||
| 0.079 | 0.022 | 0.079 | MDM2 inhibitor | |||
| 0.119 | 0.062 | 0.119 | Caspase 3 inhibitor | |||
| 0.105 | 0.049 | 0.105 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.061 | 0.005 | 0.061 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.091 | 0.035 | 0.151 | Phosphofructokinase-1 inhibitor | 0.068 0.05 DBMET01926 0.089 0.036 DBMET01928 0.143 0.019 DBMET01934 0.112 0.028 DBMET01937 0.092 0.035 DBMET01933 0.151 0.018 DBMET01938 0.098 0.033 DBMET01939 0.112 0.028 DBMET01940 0.118 0.026 DBMET01941 | DBMET01938 | |
| 0.107 | 0.053 | 0.107 | MAP kinase 8 inhibitor | |||
| 0.058 | 0.005 | 0.058 | CXC chemokine 2 receptor antagonist | |||
| 0.153 | 0.1 | 0.153 | Lipocortins synthesis antagonist | |||
| 0.09 | 0.037 | 0.09 | NMDA 2 receptor antagonist | |||
| 0.239 | 0.188 | 0.578 | Antibacterial | 0.442 0.059 DBMET01926 0.578 0.023 DBMET01927 0.575 0.023 DBMET01928 0.514 0.037 DBMET01929 0.578 0.023 DBMET01934 0.434 0.062 DBMET01935 0.436 0.062 DBMET01937 0.46 0.053 DBMET01942 0.484 0.045 DBMET01933 0.518 0.036 DBMET01936 0.511 0.037 DBMET01938 0.51 0.038 DBMET01939 0.436 0.062 DBMET01940 0.561 0.026 DBMET01941 | DBMET01934 | |
| 0.056 | 0.006 | 0.056 | Prostaglandin EP1 antagonist | |||
| 0.133 | 0.084 | 0.133 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.086 | 0.037 | 0.086 | CDC25A inhibitor | 0.073 0.052 DBMET01927 0.066 0.064 DBMET01935 0.066 0.064 DBMET01937 0.07 0.057 DBMET01942 0.074 0.051 DBMET01933 0.066 0.064 DBMET01940 | ||
| 0.135 | 0.086 | 0.135 | Pregnane X receptor agonist | |||
| 0.055 | 0.006 | 0.055 | ATP citrate lysase inhibitor | |||
| 0.159 | 0.11 | 0.159 | I kappa B kinase epsilon inhibitor | |||
| 0.17 | 0.122 | 0.17 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.15 | 0.103 | 0.15 | Neurotensin receptor agonist | |||
| 0.071 | 0.025 | 0.071 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.07 | 0.023 | 0.07 | Protein kinase C theta inhibitor | 0.052 0.051 DBMET01938 | ||
| 0.094 | 0.049 | 0.094 | Bromodomain-containing protein 2 inhibitor | |||
| 0.056 | 0.012 | 0.056 | Farnesoid X receptor agonist | |||
| 0.114 | 0.07 | 0.114 | Cholesterol synthesis inhibitor | |||
| 0.059 | 0.018 | 0.059 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.064 | 0.024 | 0.064 | Factor IXa inhibitor | 0.048 0.041 DBMET01941 | ||
| 0.059 | 0.019 | 0.059 | Glutamate (mGluR group III) agonist | |||
| 0.054 | 0.014 | 0.054 | Nerve growth factor antagonist | |||
| 0.051 | 0.012 | 0.051 | Glutamate (mGluR3) antagonist | |||
| 0.049 | 0.011 | 0.049 | Leukotriene C4 antagonist | |||
| 0.058 | 0.02 | 0.058 | Purinergic P2Y antagonist | |||
| 0.051 | 0.013 | 0.051 | Potassium channel Kv1.1 blocker | |||
| 0.051 | 0.014 | 0.051 | Retinoic acid alpha receptor agonist | |||
| 0.079 | 0.043 | 0.079 | Aminopeptidase I inhibitor | |||
| 0.056 | 0.021 | 0.056 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.157 | 0.122 | 0.157 | EphB2 antagonist | |||
| 0.048 | 0.013 | 0.048 | Integrin alpha2 antagonist | |||
| 0.041 | 0.007 | 0.041 | Kainate receptor 1 antagonist | |||
| 0.051 | 0.017 | 0.051 | Retinoid X receptor agonist | |||
| 0.048 | 0.015 | 0.048 | Retinoid X alpha receptor agonist | |||
| 0.187 | 0.154 | 0.187 | Transcription factor STAT3 inhibitor | |||
| 0.159 | 0.126 | 0.245 | Neurotrophic factor enhancer | 0.161 0.122 DBMET01926 0.245 0.042 DBMET01927 0.207 0.07 DBMET01928 0.162 0.12 DBMET01929 0.167 0.113 DBMET01934 0.149 0.14 DBMET01935 0.195 0.082 DBMET01937 0.202 0.075 DBMET01942 0.23 0.052 DBMET01933 0.196 0.08 DBMET01938 0.196 0.08 DBMET01939 0.195 0.082 DBMET01940 | DBMET01927 | |
| 0.107 | 0.075 | 0.158 | Photosensitizer | 0.111 0.07 DBMET01926 0.114 0.065 DBMET01928 0.104 0.081 DBMET01929 0.109 0.072 DBMET01935 0.111 0.07 DBMET01937 0.107 0.075 DBMET01942 0.158 0.026 DBMET01933 0.098 0.092 DBMET01936 0.104 0.081 DBMET01939 0.111 0.07 DBMET01940 0.1 0.089 DBMET01941 | DBMET01933 | |
| 0.062 | 0.031 | 0.062 | Thromboxane antagonist | |||
| 0.048 | 0.017 | 0.048 | GABA uptake inhibitor | |||
| 0.058 | 0.027 | 0.058 | H+/K+-transporting ATPase inhibitor | |||
| 0.074 | 0.043 | 0.074 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.06 | 0.029 | 0.06 | NMDA 2A receptor antagonist | |||
| 0.142 | 0.111 | 0.142 | Tumour necrosis factor antagonist | |||
| 0.103 | 0.072 | 0.151 | Protein kinase C gamma inhibitor | 0.093 0.09 DBMET01926 0.097 0.083 DBMET01935 0.124 0.049 DBMET01937 0.109 0.064 DBMET01942 0.151 0.031 DBMET01933 0.145 0.035 DBMET01938 0.106 0.068 DBMET01939 0.124 0.049 DBMET01940 0.132 0.043 DBMET01941 | DBMET01933 | |
| 0.037 | 0.007 | 0.037 | Nicotinic acid receptor 2 antagonist | |||
| 0.09 | 0.061 | 0.118 | Glutamate release inhibitor | 0.092 0.057 DBMET01926 0.085 0.073 DBMET01929 0.118 0.023 DBMET01937 0.083 0.08 DBMET01942 0.109 0.031 DBMET01939 0.118 0.023 DBMET01940 0.095 0.051 DBMET01941 | DBMET01940 | |
| 0.037 | 0.008 | 0.037 | Kainate receptor 5 antagonist | |||
| 0.058 | 0.029 | 0.058 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.059 | 0.031 | 0.059 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.044 | 0.016 | 0.044 | Glutamate (mGluR8) agonist | |||
| 0.068 | 0.04 | 0.068 | Purinergic P2 antagonist | |||
| 0.156 | 0.129 | 0.19 | Growth factor agonist | 0.174 0.096 DBMET01937 0.19 0.074 DBMET01933 0.175 0.094 DBMET01938 0.149 0.144 DBMET01939 0.174 0.096 DBMET01940 | DBMET01933 | |
| 0.049 | 0.022 | 0.049 | Glutamate (mGluR4) antagonist | |||
| 0.041 | 0.015 | 0.041 | Purinergic P2Y2 antagonist | |||
| 0.083 | 0.057 | 0.083 | Glutathione S-transferase inhibitor | |||
| 0.034 | 0.009 | 0.034 | Integrin alpha2beta1 antagonist | |||
| 0.081 | 0.055 | 0.133 | Glycine receptor antagonist | 0.133 0.012 DBMET01926 0.073 0.07 DBMET01927 0.101 0.032 DBMET01928 0.102 0.031 DBMET01929 0.095 0.037 DBMET01934 0.089 0.044 DBMET01935 0.11 0.024 DBMET01937 0.1 0.033 DBMET01942 0.096 0.036 DBMET01933 0.094 0.038 DBMET01936 0.106 0.027 DBMET01938 0.08 0.057 DBMET01939 0.11 0.024 DBMET01940 0.121 0.017 DBMET01941 | DBMET01926 | |
| 0.038 | 0.012 | 0.038 | Glutamate (mGluR3) agonist | |||
| 0.038 | 0.013 | 0.038 | Purinergic P2Y14 antagonist | |||
| 0.041 | 0.015 | 0.041 | Glutamate (mGluR4) agonist | |||
| 0.113 | 0.088 | 0.113 | Cyclooxygenase 2 inhibitor | 0.105 0.098 DBMET01942 0.103 0.101 DBMET01938 | ||
| 0.114 | 0.089 | 0.114 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.029 | 0.004 | 0.029 | Nicotinic acid receptor 1 antagonist | |||
| 0.041 | 0.016 | 0.041 | Glutamate (mGluR8) antagonist | |||
| 0.077 | 0.053 | 0.077 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.055 | 0.032 | 0.055 | Thromboxane A2 antagonist | |||
| 0.103 | 0.08 | 0.103 | Anesthetic local | |||
| 0.045 | 0.022 | 0.045 | Urate transporter 1 inhibitor | |||
| 0.125 | 0.103 | 0.125 | MAP3K9 inhibitor | |||
| 0.046 | 0.025 | 0.046 | Glutamate (mGluR group III) antagonist | |||
| 0.052 | 0.031 | 0.052 | Plasminogen activator inhibitor antagonist | |||
| 0.055 | 0.034 | 0.066 | Heparanase inhibitor | 0.053 0.036 DBMET01926 0.062 0.02 DBMET01928 0.056 0.031 DBMET01934 0.058 0.026 DBMET01937 0.056 0.031 DBMET01933 0.05 0.046 DBMET01939 0.058 0.026 DBMET01940 0.066 0.015 DBMET01941 | DBMET01941 | |
| 0.064 | 0.043 | 0.064 | Kallikrein 7 inhibitor | |||
| 0.112 | 0.092 | 0.112 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.037 | 0.017 | 0.037 | Protein kinase (CK2) beta inhibitor | |||
| 0.196 | 0.176 | 0.196 | Thioredoxin glutathione reductase inhibitor | |||
| 0.032 | 0.012 | 0.032 | Calcium-sensing receptor agonist | |||
| 0.127 | 0.107 | 0.127 | Neuropeptide Y1 antagonist | |||
| 0.092 | 0.074 | 0.092 | Anabolic | |||
| 0.095 | 0.077 | 0.165 | AMP-activated protein kinase stimulant | 0.121 0.048 DBMET01926 0.138 0.036 DBMET01928 0.12 0.049 DBMET01929 0.101 0.069 DBMET01934 0.136 0.038 DBMET01935 0.154 0.026 DBMET01937 0.135 0.038 DBMET01942 0.124 0.046 DBMET01933 0.165 0.02 DBMET01936 0.135 0.038 DBMET01938 0.153 0.027 DBMET01939 0.154 0.026 DBMET01940 0.164 0.02 DBMET01941 | DBMET01936 | |
| 0.123 | 0.105 | 0.123 | Src kinase inhibitor | |||
| 0.038 | 0.021 | 0.038 | Phosphoglycerate kinase inhibitor | |||
| 0.08 | 0.064 | 0.08 | Bcr-Abl kinase inhibitor | |||
| 0.131 | 0.115 | 0.171 | CF transmembrane conductance regulator agonist | 0.128 0.123 DBMET01926 0.132 0.114 DBMET01927 0.128 0.122 DBMET01929 0.142 0.09 DBMET01935 0.132 0.114 DBMET01937 0.147 0.081 DBMET01942 0.171 0.045 DBMET01933 0.132 0.113 DBMET01939 0.132 0.114 DBMET01940 | DBMET01933 | |
| 0.089 | 0.073 | 0.243 | Xanthine oxidase inhibitor | 0.14 0.039 DBMET01926 0.174 0.026 DBMET01928 0.129 0.043 DBMET01929 0.088 0.075 DBMET01934 0.159 0.031 DBMET01935 0.163 0.03 DBMET01937 0.195 0.02 DBMET01942 0.236 0.014 DBMET01933 0.13 0.043 DBMET01936 0.243 0.013 DBMET01938 0.153 0.033 DBMET01939 0.163 0.03 DBMET01940 0.199 0.02 DBMET01941 | DBMET01938 | |
| 0.041 | 0.025 | 0.041 | Dihydropteroate synthase inhibitor | |||
| 0.102 | 0.086 | 0.184 | Cell adhesion inhibitor | 0.16 0.04 DBMET01926 0.153 0.045 DBMET01927 0.141 0.052 DBMET01928 0.101 0.087 DBMET01929 0.128 0.06 DBMET01934 0.123 0.063 DBMET01935 0.162 0.039 DBMET01937 0.141 0.052 DBMET01942 0.161 0.04 DBMET01933 0.151 0.046 DBMET01936 0.118 0.067 DBMET01938 0.104 0.082 DBMET01939 0.162 0.039 DBMET01940 0.184 0.029 DBMET01941 | DBMET01941 | |
| 0.042 | 0.027 | 0.042 | Kainate receptor agonist | |||
| 0.054 | 0.039 | 0.054 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.019 | 0.004 | 0.019 | Thrombopoietin agonist | |||
| 0.049 | 0.034 | 0.049 | Topoisomerase II beta inhibitor | |||
| 0.053 | 0.038 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.067 | 0.053 | 0.105 | Protein kinase C beta inhibitor | 0.07 0.047 DBMET01926 0.069 0.05 DBMET01935 0.081 0.028 DBMET01937 0.077 0.034 DBMET01942 0.105 0.011 DBMET01933 0.096 0.015 DBMET01938 0.071 0.046 DBMET01939 0.081 0.028 DBMET01940 0.08 0.03 DBMET01941 | DBMET01933 | |
| 0.077 | 0.062 | 0.077 | Adrenaline agonist | |||
| 0.08 | 0.067 | 0.08 | Estrogen-related receptor beta agonist | |||
| 0.034 | 0.021 | 0.034 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.06 | 0.047 | 0.065 | Prostaglandin F2 alpha antagonist | 0.065 0.039 DBMET01936 | DBMET01936 | |
| 0.022 | 0.01 | 0.022 | Retinoic acid beta receptor agonist | |||
| 0.037 | 0.024 | 0.037 | Kainate receptor 2 antagonist | |||
| 0.049 | 0.037 | 0.049 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.022 | 0.011 | 0.022 | Retinoid X beta receptor antagonist | |||
| 0.064 | 0.054 | 0.064 | Carbonic anhydrase VA inhibitor | |||
| 0.028 | 0.018 | 0.028 | NMDA 2D receptor antagonist | |||
| 0.041 | 0.032 | 0.041 | Guanylate cyclase inhibitor | |||
| 0.037 | 0.028 | 0.037 | TRPM8 blocker | |||
| 0.024 | 0.015 | 0.024 | Retinoic acid receptor agonist | |||
| 0.061 | 0.052 | 0.186 | Neuraminidase (influenza) inhibitor | 0.09 0.02 DBMET01926 0.066 0.042 DBMET01927 0.089 0.02 DBMET01928 0.082 0.024 DBMET01929 0.097 0.017 DBMET01934 0.087 0.021 DBMET01935 0.082 0.024 DBMET01937 0.096 0.018 DBMET01942 0.186 0.005 DBMET01932 0.117 0.013 DBMET01933 0.06 0.053 DBMET01936 0.096 0.018 DBMET01938 0.076 0.028 DBMET01939 0.082 0.024 DBMET01940 0.128 0.01 DBMET01941 | DBMET01932 | |
| 0.048 | 0.039 | 0.048 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.028 | 0.019 | 0.057 | Uridine phosphorylase inhibitor | 0.031 0.017 DBMET01928 0.057 0.006 DBMET01934 0.034 0.015 DBMET01937 0.033 0.016 DBMET01933 0.025 0.023 DBMET01939 0.034 0.015 DBMET01940 0.031 0.017 DBMET01941 | DBMET01934 | |
| 0.179 | 0.17 | 0.179 | Transcription factor STAT inhibitor | |||
| 0.033 | 0.025 | 0.033 | RNA-directed RNA polymerase inhibitor | |||
| 0.023 | 0.015 | 0.023 | Retinoic acid gamma receptor agonist | |||
| 0.048 | 0.04 | 0.048 | Potassium channel (Inward rectifier) activator | |||
| 0.049 | 0.041 | 0.049 | Ornithine carbamoyltransferase inhibitor | |||
| 0.03 | 0.022 | 0.03 | Elastase 3B inhibitor | |||
| 0.03 | 0.022 | 0.03 | Elastase 2B inhibitor | |||
| 0.03 | 0.022 | 0.03 | Elastase 3A inhibitor | |||
| 0.093 | 0.086 | 0.146 | Protein-tyrosine phosphatase 1B inhibitor | 0.134 0.053 DBMET01929 0.097 0.081 DBMET01935 0.1 0.078 DBMET01937 0.103 0.075 DBMET01942 0.139 0.05 DBMET01933 0.122 0.062 DBMET01938 0.146 0.047 DBMET01939 0.1 0.078 DBMET01940 0.138 0.051 DBMET01941 | DBMET01939 | |
| 0.023 | 0.016 | 0.023 | Retinoid X gamma receptor agonist | |||
| 0.046 | 0.039 | 0.046 | Potassium channel (ATP-sensitive) activator | |||
| 0.027 | 0.02 | 0.027 | Retinoid X gamma receptor antagonist | |||
| 0.055 | 0.048 | 0.055 | Androgen agonist | |||
| 0.04 | 0.033 | 0.04 | Angiotensin AT1 receptor antagonist | |||
| 0.07 | 0.064 | 0.07 | MAP kinase 10 inhibitor | |||
| 0.022 | 0.016 | 0.022 | Beta 1 adrenoreceptor agonist | |||
| 0.02 | 0.014 | 0.02 | Retinoic acid alpha receptor antagonist | |||
| 0.032 | 0.026 | 0.032 | Fumarate hydratase inhibitor | |||
| 0.038 | 0.033 | 0.052 | Thymidine kinase inhibitor | 0.048 0.02 DBMET01926 0.037 0.035 DBMET01927 0.052 0.017 DBMET01937 0.052 0.017 DBMET01940 0.04 0.029 DBMET01941 | DBMET01940 | |
| 0.021 | 0.015 | 0.021 | Retinoid X beta receptor agonist | |||
| 0.036 | 0.03 | 0.036 | Retinoid X receptor antagonist | |||
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | |||
| 0.042 | 0.037 | 0.042 | Carbonic anhydrase VII inhibitor | |||
| 0.03 | 0.025 | 0.03 | Sirtuin 2 inhibitor | |||
| 0.034 | 0.03 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.032 | 0.028 | 0.032 | Retinoid X alpha receptor antagonist | |||
| 0.038 | 0.035 | 0.038 | CF transmembrane conductance regulator antagonist | |||
| 0.047 | 0.044 | 0.047 | CD45 antagonist | |||
| 0.035 | 0.032 | 0.035 | DNA gyrase subunit B inhibitor | |||
| 0.044 | 0.041 | 0.048 | Carbonic anhydrase XIV inhibitor | 0.048 0.036 DBMET01933 | DBMET01933 | |
| 0.079 | 0.076 | 0.083 | Interleukin 5 antagonist | 0.083 0.066 DBMET01936 | DBMET01936 | |
| 0.083 | 0.081 | 0.083 | Ephrin antagonist | |||
| 0.058 | 0.056 | 0.058 | Carbonic anhydrase V inhibitor | |||
| 0.02 | 0.018 | 0.02 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.044 | 0.043 | 0.044 | Potassium channel (Inward rectifier) blocker | |||
| 0.047 | 0.046 | 0.047 | Maillard reaction inhibitor | |||
| 0.231 | 0.234 | 0.753 | Cyclophilin D inhibitor | 0.525 0.043 DBMET01926 0.454 0.065 DBMET01927 0.634 0.022 DBMET01928 0.486 0.055 DBMET01929 0.753 0.009 DBMET01934 0.495 0.052 DBMET01935 0.556 0.036 DBMET01937 0.512 0.047 DBMET01942 0.532 0.041 DBMET01933 0.572 0.033 DBMET01936 0.506 0.048 DBMET01938 0.517 0.045 DBMET01939 0.556 0.036 DBMET01940 0.559 0.035 DBMET01941 | DBMET01934 | |
| 0.028 | 0.036 | 0.033 | Protein kinase C beta II inhibitor | 0.033 0.021 DBMET01933 | DBMET01933 | |
| 0.088 | 0.096 | 0.138 | Mucolytic | 0.095 0.085 DBMET01927 0.104 0.072 DBMET01937 0.138 0.04 DBMET01933 0.114 0.061 DBMET01938 0.11 0.065 DBMET01939 0.104 0.072 DBMET01940 0.092 0.09 DBMET01941 | DBMET01933 | |
| 0.129 | 0.137 | 0.201 | Interleukin antagonist | 0.201 0.083 DBMET01927 0.146 0.121 DBMET01935 0.157 0.113 DBMET01942 0.187 0.091 DBMET01933 | DBMET01927 | |
| 0.049 | 0.058 | 0.163 | Neuraminidase inhibitor | 0.063 0.039 DBMET01926 0.074 0.03 DBMET01928 0.057 0.047 DBMET01929 0.077 0.028 DBMET01934 0.065 0.038 DBMET01935 0.058 0.045 DBMET01937 0.068 0.035 DBMET01942 0.163 0.005 DBMET01932 0.081 0.025 DBMET01933 0.067 0.036 DBMET01938 0.058 0.045 DBMET01940 0.094 0.018 DBMET01941 | DBMET01932 | |
| 0.051 | 0.06 | 0.059 | HIV-1 integrase (3'-Processing) inhibitor | 0.059 0.048 DBMET01933 0.059 0.048 DBMET01938 | DBMET01938 | |
| 0.038 | 0.048 | 0.103 | Neuraminidase (Influenza A) inhibitor | 0.103 0.004 DBMET01932 0.048 0.028 DBMET01941 | DBMET01932 | |
| 0.05 | 0.066 | 0.058 | DNA gyrase inhibitor | 0.058 0.051 DBMET01928 | DBMET01928 | |
| 0.02 | 0.037 | 0.024 | Vanilloid 2 agonist | 0.024 0.02 DBMET01928 | DBMET01928 | |
| 0.143 | 0.161 | 0.455 | Immunostimulant | 0.396 0.051 DBMET01926 0.383 0.055 DBMET01927 0.378 0.056 DBMET01928 0.367 0.06 DBMET01929 0.426 0.043 DBMET01934 0.399 0.05 DBMET01935 0.45 0.037 DBMET01937 0.404 0.048 DBMET01942 0.449 0.037 DBMET01933 0.404 0.048 DBMET01936 0.455 0.036 DBMET01938 0.423 0.043 DBMET01939 0.45 0.037 DBMET01940 0.416 0.045 DBMET01941 | DBMET01938 | |
| 0.08 | 0.098 | 0.112 | Interleukin 12 antagonist | 0.112 0.037 DBMET01927 0.101 0.053 DBMET01928 0.097 0.059 DBMET01935 0.09 0.072 DBMET01942 0.108 0.043 DBMET01933 0.108 0.043 DBMET01936 | DBMET01927 | |
| 0.117 | 0.142 | 0.243 | Melanin inhibitor | 0.161 0.068 DBMET01926 0.181 0.051 DBMET01927 0.173 0.057 DBMET01928 0.158 0.071 DBMET01929 0.131 0.112 DBMET01934 0.166 0.063 DBMET01935 0.156 0.074 DBMET01937 0.2 0.041 DBMET01942 0.128 0.119 DBMET01932 0.243 0.03 DBMET01933 0.223 0.034 DBMET01936 0.201 0.04 DBMET01938 0.153 0.078 DBMET01939 0.156 0.074 DBMET01940 0.145 0.089 DBMET01941 | DBMET01933 | |
| 0.037 | 0.063 | 0.073 | Glucose-6-phosphate isomerase inhibitor | 0.056 0.022 DBMET01926 0.049 0.032 DBMET01927 0.051 0.028 DBMET01928 0.048 0.032 DBMET01929 0.067 0.014 DBMET01934 0.045 0.039 DBMET01935 0.073 0.011 DBMET01937 0.045 0.04 DBMET01942 0.067 0.014 DBMET01933 0.059 0.019 DBMET01938 0.063 0.016 DBMET01939 0.073 0.011 DBMET01940 0.059 0.019 DBMET01941 | DBMET01940 | |
| 0.04 | 0.067 | 0.053 | HIV-1 integrase (Strand Transfer) inhibitor | 0.053 0.047 DBMET01936 | DBMET01936 | |
| 0.184 | 0.211 | 0.221 | Sodium/bile acid cotransporter inhibitor | 0.221 0.161 DBMET01933 | DBMET01933 | |
| 0.042 | 0.069 | 0.047 | Factor III inhibitor | 0.047 0.043 DBMET01928 | DBMET01928 | |
| 0.183 | 0.214 | 0.598 | Immunosuppressant | 0.492 0.035 DBMET01926 0.364 0.079 DBMET01927 0.488 0.036 DBMET01928 0.494 0.035 DBMET01929 0.466 0.042 DBMET01934 0.466 0.043 DBMET01935 0.488 0.036 DBMET01937 0.471 0.041 DBMET01942 0.369 0.077 DBMET01932 0.519 0.028 DBMET01933 0.598 0.013 DBMET01936 0.483 0.038 DBMET01938 0.49 0.036 DBMET01939 0.488 0.036 DBMET01940 0.494 0.035 DBMET01941 | DBMET01936 | |
| 0.017 | 0.048 | 0.098 | Sodium/glucose cotransporter 2 inhibitor | 0.043 0.008 DBMET01926 0.098 0.003 DBMET01927 0.057 0.005 DBMET01928 0.03 0.013 DBMET01929 0.089 0.003 DBMET01934 0.035 0.01 DBMET01935 0.077 0.004 DBMET01937 0.04 0.008 DBMET01942 0.034 0.01 DBMET01932 0.031 0.012 DBMET01933 0.052 0.006 DBMET01936 0.032 0.011 DBMET01938 0.059 0.005 DBMET01939 0.077 0.004 DBMET01940 0.034 0.01 DBMET01941 | DBMET01927 | |
| 0.118 | 0.155 | 0.481 | Hepatoprotectant | 0.429 0.011 DBMET01926 0.289 0.033 DBMET01927 0.375 0.016 DBMET01928 0.416 0.012 DBMET01929 0.317 0.025 DBMET01934 0.411 0.012 DBMET01935 0.458 0.009 DBMET01937 0.422 0.011 DBMET01942 0.295 0.031 DBMET01932 0.481 0.008 DBMET01933 0.363 0.017 DBMET01936 0.476 0.008 DBMET01938 0.444 0.01 DBMET01939 0.458 0.009 DBMET01940 0.444 0.01 DBMET01941 | DBMET01933 | |
| 0.175 | 0.212 | 0.561 | Antithrombotic | 0.48 0.032 DBMET01926 0.235 0.138 DBMET01927 0.428 0.043 DBMET01928 0.393 0.051 DBMET01929 0.465 0.035 DBMET01934 0.422 0.044 DBMET01935 0.561 0.021 DBMET01937 0.472 0.033 DBMET01942 0.197 0.181 DBMET01932 0.535 0.024 DBMET01933 0.376 0.056 DBMET01936 0.407 0.047 DBMET01938 0.476 0.033 DBMET01939 0.561 0.021 DBMET01940 0.556 0.021 DBMET01941 | DBMET01940 | |
| 0.163 | 0.2 | 0.268 | Hypoxia-inducible factor 1 alpha inhibitor | 0.268 0.085 DBMET01927 0.201 0.15 DBMET01935 0.203 0.148 DBMET01942 0.248 0.103 DBMET01933 | DBMET01927 | |
| 0.018 | 0.055 | 0.086 | Sodium/glucose cotransporter inhibitor | 0.04 0.007 DBMET01926 0.086 0.003 DBMET01927 0.045 0.006 DBMET01928 0.03 0.011 DBMET01929 0.076 0.004 DBMET01934 0.034 0.009 DBMET01935 0.071 0.004 DBMET01937 0.038 0.007 DBMET01942 0.028 0.014 DBMET01932 0.032 0.01 DBMET01933 0.053 0.005 DBMET01936 0.031 0.01 DBMET01938 0.052 0.005 DBMET01939 0.071 0.004 DBMET01940 0.033 0.009 DBMET01941 | DBMET01927 | |
| 0.147 | 0.187 | 0.17 | 5 Hydroxytryptamine release stimulant | 0.17 0.153 DBMET01927 | DBMET01927 | |
| 0.136 | 0.179 | 0.325 | Spasmolytic | 0.239 0.096 DBMET01926 0.164 0.15 DBMET01928 0.204 0.116 DBMET01929 0.237 0.097 DBMET01935 0.211 0.111 DBMET01937 0.269 0.083 DBMET01942 0.325 0.061 DBMET01933 0.21 0.112 DBMET01938 0.184 0.133 DBMET01939 0.211 0.111 DBMET01940 0.17 0.145 DBMET01941 | DBMET01933 | |
| 0.07 | 0.122 | 0.109 | T cell inhibitor | 0.08 0.065 DBMET01928 0.109 0.018 DBMET01936 | DBMET01936 | |
| 0.062 | 0.119 | 0.122 | Mediator release inhibitor | 0.091 0.081 DBMET01942 0.122 0.046 DBMET01933 0.096 0.075 DBMET01941 | DBMET01933 | |
| 0.07 | 0.128 | 0.118 | Adenylate cyclase inhibitor | 0.102 0.082 DBMET01933 0.118 0.069 DBMET01939 | DBMET01939 | |
| 0.169 | 0.232 | 0.512 | Apoptosis antagonist | 0.414 0.035 DBMET01926 0.274 0.105 DBMET01927 0.308 0.08 DBMET01928 0.366 0.049 DBMET01929 0.318 0.073 DBMET01934 0.388 0.042 DBMET01935 0.468 0.025 DBMET01937 0.425 0.032 DBMET01942 0.472 0.024 DBMET01933 0.313 0.077 DBMET01936 0.512 0.019 DBMET01938 0.409 0.036 DBMET01939 0.468 0.025 DBMET01940 0.434 0.03 DBMET01941 | DBMET01938 | |
| 0.145 | 0.209 | 0.312 | Peptidyltransferase inhibitor | 0.262 0.043 DBMET01926 0.292 0.028 DBMET01927 0.295 0.027 DBMET01928 0.254 0.048 DBMET01929 0.302 0.024 DBMET01934 0.251 0.05 DBMET01935 0.254 0.048 DBMET01937 0.261 0.043 DBMET01942 0.227 0.069 DBMET01932 0.277 0.034 DBMET01933 0.312 0.021 DBMET01936 0.255 0.047 DBMET01938 0.247 0.053 DBMET01939 0.254 0.048 DBMET01940 0.267 0.04 DBMET01941 | DBMET01936 | |
| 0.069 | 0.135 | 0.168 | DNA polymerase I inhibitor | 0.131 0.061 DBMET01926 0.102 0.084 DBMET01927 0.108 0.079 DBMET01928 0.129 0.062 DBMET01929 0.114 0.073 DBMET01934 0.125 0.065 DBMET01935 0.148 0.05 DBMET01937 0.146 0.052 DBMET01942 0.168 0.04 DBMET01933 0.103 0.083 DBMET01938 0.145 0.052 DBMET01939 0.148 0.05 DBMET01940 0.147 0.051 DBMET01941 | DBMET01933 | |
| 0.012 | 0.077 | 0.048 | Prostacyclin antagonist | 0.048 0.014 DBMET01941 | DBMET01941 | |
| 0.089 | 0.155 | 0.115 | Antibacterial (Helicobacter pylori) | 0.108 0.102 DBMET01933 0.115 0.09 DBMET01938 | DBMET01938 | |
| 0.063 | 0.129 | 0.165 | Expectorant | 0.102 0.066 DBMET01927 0.111 0.058 DBMET01928 0.09 0.081 DBMET01929 0.096 0.073 DBMET01934 0.108 0.06 DBMET01937 0.092 0.079 DBMET01942 0.165 0.03 DBMET01933 0.122 0.049 DBMET01938 0.117 0.053 DBMET01939 0.108 0.06 DBMET01940 0.098 0.071 DBMET01941 | DBMET01933 | |
| 0.084 | 0.152 | 0.142 | Interleukin 4 antagonist | 0.122 0.083 DBMET01927 0.124 0.079 DBMET01929 0.134 0.066 DBMET01935 0.124 0.08 DBMET01942 0.142 0.058 DBMET01933 0.127 0.075 DBMET01939 0.114 0.095 DBMET01941 | DBMET01933 | |
| 0.073 | 0.148 | 0.117 | Microtubule formation inhibitor | 0.1 0.092 DBMET01926 0.101 0.09 DBMET01929 0.117 0.064 DBMET01933 | DBMET01933 | |
| 0.03 | 0.106 | 0.139 | Protein kinase C eta inhibitor | 0.106 0.015 DBMET01926 0.094 0.019 DBMET01929 0.104 0.016 DBMET01935 0.116 0.013 DBMET01937 0.117 0.013 DBMET01942 0.139 0.009 DBMET01933 0.055 0.038 DBMET01936 0.13 0.01 DBMET01938 0.106 0.015 DBMET01939 0.116 0.013 DBMET01940 0.124 0.011 DBMET01941 | DBMET01933 | |
| 0.101 | 0.177 | 0.131 | Adenylate cyclase stimulant | 0.131 0.099 DBMET01933 | DBMET01933 | |
| 0.054 | 0.134 | 0.08 | Falcipain 2 inhibitor | 0.08 0.069 DBMET01928 | DBMET01928 | |
| 0.055 | 0.137 | 0.082 | Falcipain inhibitor | 0.082 0.071 DBMET01928 | DBMET01928 | |
| 0.047 | 0.136 | 0.285 | Monophenol monooxygenase inhibitor | 0.121 0.061 DBMET01928 0.1 0.076 DBMET01929 0.107 0.071 DBMET01935 0.11 0.068 DBMET01937 0.143 0.05 DBMET01942 0.285 0.019 DBMET01933 0.164 0.042 DBMET01938 0.125 0.058 DBMET01939 0.11 0.068 DBMET01940 0.11 0.068 DBMET01941 | DBMET01933 | |
| 0.211 | 0.303 | 0.659 | Caspase 9 stimulant | 0.447 0.085 DBMET01926 0.513 0.055 DBMET01927 0.377 0.125 DBMET01928 0.45 0.083 DBMET01929 0.372 0.129 DBMET01934 0.449 0.083 DBMET01935 0.516 0.054 DBMET01937 0.509 0.056 DBMET01942 0.486 0.066 DBMET01932 0.65 0.03 DBMET01933 0.659 0.029 DBMET01938 0.519 0.053 DBMET01939 0.516 0.054 DBMET01940 0.365 0.134 DBMET01941 | DBMET01938 | |
| 0.02 | 0.115 | 0.08 | Mannosidase inhibitor | 0.051 0.024 DBMET01926 0.047 0.029 DBMET01927 0.06 0.017 DBMET01928 0.04 0.039 DBMET01929 0.062 0.015 DBMET01934 0.08 0.009 DBMET01937 0.061 0.016 DBMET01933 0.053 0.023 DBMET01938 0.065 0.014 DBMET01939 0.08 0.009 DBMET01940 0.066 0.014 DBMET01941 | DBMET01940 | |
| 0.072 | 0.171 | 0.193 | Thrombolytic | 0.154 0.079 DBMET01926 0.12 0.111 DBMET01927 0.193 0.056 DBMET01928 0.163 0.072 DBMET01929 0.157 0.077 DBMET01934 0.159 0.075 DBMET01935 0.166 0.07 DBMET01937 0.155 0.078 DBMET01942 0.18 0.062 DBMET01933 0.14 0.09 DBMET01936 0.146 0.085 DBMET01938 0.174 0.065 DBMET01939 0.166 0.07 DBMET01940 0.183 0.06 DBMET01941 | DBMET01928 | |
| 0.021 | 0.126 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.026 DBMET01933 | DBMET01933 | |
| 0.026 | 0.131 | 0.046 | Cholesterol esterase inhibitor | 0.046 0.037 DBMET01938 | DBMET01938 | |
| 0.017 | 0.126 | 0.036 | Ceramide glucosyltransferase inhibitor | 0.036 0.024 DBMET01937 0.036 0.024 DBMET01940 | DBMET01940 | |
| 0.057 | 0.169 | 0.218 | Transcription factor NF kappa B stimulant | 0.178 0.011 DBMET01926 0.147 0.017 DBMET01927 0.134 0.02 DBMET01928 0.169 0.013 DBMET01929 0.149 0.016 DBMET01934 0.198 0.009 DBMET01935 0.218 0.008 DBMET01937 0.166 0.013 DBMET01942 0.13 0.021 DBMET01932 0.195 0.01 DBMET01933 0.153 0.015 DBMET01936 0.159 0.014 DBMET01938 0.206 0.009 DBMET01939 0.218 0.008 DBMET01940 0.18 0.011 DBMET01941 | DBMET01940 | |
| 0.029 | 0.143 | 0.057 | Squalene epoxidase inhibitor | 0.046 0.044 DBMET01942 0.057 0.023 DBMET01933 0.053 0.029 DBMET01938 | DBMET01933 | |
| 0.121 | 0.234 | 0.486 | Hypoglycemic | 0.26 0.071 DBMET01926 0.291 0.056 DBMET01927 0.38 0.031 DBMET01928 0.235 0.086 DBMET01929 0.486 0.016 DBMET01934 0.259 0.072 DBMET01935 0.315 0.048 DBMET01937 0.29 0.056 DBMET01942 0.333 0.042 DBMET01933 0.327 0.044 DBMET01936 0.24 0.083 DBMET01938 0.284 0.058 DBMET01939 0.315 0.048 DBMET01940 0.295 0.054 DBMET01941 | DBMET01934 | |
| 0.071 | 0.186 | 0.134 | Protein kinase C nu inhibitor | 0.134 0.079 DBMET01933 | DBMET01933 | |
| 0.087 | 0.204 | 0.119 | Vanilloid 1 agonist | 0.119 0.091 DBMET01933 | DBMET01933 | |
| 0.024 | 0.142 | 0.077 | Purinergic P2X2 antagonist | 0.077 0.042 DBMET01938 | DBMET01938 | |
| 0.032 | 0.151 | 0.108 | Na+ K+ transporting ATPase inhibitor | 0.094 0.037 DBMET01926 0.088 0.042 DBMET01927 0.098 0.034 DBMET01928 0.086 0.044 DBMET01929 0.087 0.043 DBMET01934 0.087 0.044 DBMET01935 0.101 0.031 DBMET01937 0.091 0.04 DBMET01942 0.108 0.025 DBMET01933 0.105 0.027 DBMET01936 0.103 0.029 DBMET01938 0.095 0.036 DBMET01939 0.101 0.031 DBMET01940 0.083 0.047 DBMET01941 | DBMET01933 | |
| 0.089 | 0.21 | 0.159 | Hemostatic | 0.159 0.058 DBMET01927 0.123 0.109 DBMET01928 0.135 0.088 DBMET01934 0.139 0.083 DBMET01937 0.141 0.079 DBMET01933 0.124 0.106 DBMET01936 0.139 0.083 DBMET01940 0.132 0.093 DBMET01941 | DBMET01927 | |
| 0.068 | 0.19 | 0.104 | Toll-Like receptor 2 antagonist | 0.104 0.098 DBMET01933 | DBMET01933 | |
| 0.023 | 0.151 | 0.331 | Selectin antagonist | 0.319 0.005 DBMET01926 0.294 0.006 DBMET01927 0.319 0.005 DBMET01928 0.301 0.005 DBMET01929 0.254 0.008 DBMET01934 0.3 0.005 DBMET01935 0.33 0.004 DBMET01937 0.305 0.005 DBMET01942 0.246 0.008 DBMET01932 0.331 0.004 DBMET01933 0.314 0.005 DBMET01936 0.317 0.005 DBMET01938 0.313 0.005 DBMET01939 0.33 0.004 DBMET01940 0.33 0.004 DBMET01941 | DBMET01933 | |
| 0.024 | 0.153 | 0.087 | Alpha-mannosidase inhibitor | 0.062 0.024 DBMET01926 0.059 0.028 DBMET01927 0.061 0.025 DBMET01928 0.051 0.041 DBMET01929 0.064 0.022 DBMET01934 0.087 0.009 DBMET01937 0.07 0.016 DBMET01933 0.064 0.023 DBMET01938 0.072 0.016 DBMET01939 0.087 0.009 DBMET01940 0.066 0.02 DBMET01941 | DBMET01940 | |
| 0.055 | 0.193 | 0.189 | Alkylator | 0.112 0.075 DBMET01926 0.101 0.087 DBMET01929 0.13 0.059 DBMET01934 0.124 0.065 DBMET01935 0.159 0.042 DBMET01937 0.119 0.069 DBMET01942 0.189 0.03 DBMET01933 0.127 0.061 DBMET01936 0.142 0.051 DBMET01938 0.145 0.049 DBMET01939 0.159 0.042 DBMET01940 0.104 0.084 DBMET01941 | DBMET01933 | |
| 0.053 | 0.194 | 0.09 | Protein kinase C zeta inhibitor | 0.09 0.066 DBMET01938 | DBMET01938 | |
| 0.027 | 0.168 | 0.095 | Glucose-6-phosphate translocase inhibitor | 0.054 0.031 DBMET01928 0.051 0.037 DBMET01937 0.053 0.034 DBMET01942 0.055 0.03 DBMET01933 0.095 0.007 DBMET01936 0.081 0.01 DBMET01938 0.051 0.037 DBMET01939 0.051 0.037 DBMET01940 0.051 0.036 DBMET01941 | DBMET01936 | |
| 0.058 | 0.206 | 0.197 | Toll-Like receptor 4 antagonist | 0.193 0.007 DBMET01926 0.15 0.021 DBMET01927 0.171 0.012 DBMET01928 0.183 0.009 DBMET01929 0.138 0.029 DBMET01934 0.186 0.008 DBMET01935 0.196 0.007 DBMET01937 0.193 0.007 DBMET01942 0.168 0.013 DBMET01932 0.197 0.007 DBMET01933 0.166 0.014 DBMET01936 0.189 0.008 DBMET01938 0.185 0.009 DBMET01939 0.196 0.007 DBMET01940 0.191 0.008 DBMET01941 | DBMET01933 | |
| 0.016 | 0.165 | 0.047 | Aldose reductase inhibitor | 0.045 0.044 DBMET01933 0.047 0.042 DBMET01938 | DBMET01938 | |
| 0.051 | 0.202 | 0.174 | Thioredoxin inhibitor | 0.139 0.021 DBMET01926 0.137 0.022 DBMET01927 0.159 0.014 DBMET01928 0.129 0.025 DBMET01929 0.136 0.022 DBMET01934 0.142 0.019 DBMET01935 0.144 0.019 DBMET01937 0.146 0.018 DBMET01942 0.093 0.058 DBMET01932 0.166 0.013 DBMET01933 0.161 0.014 DBMET01936 0.174 0.011 DBMET01938 0.135 0.023 DBMET01939 0.144 0.019 DBMET01940 0.125 0.028 DBMET01941 | DBMET01938 | |
| 0.045 | 0.197 | 0.121 | ATPase (Vacuolar H+) inhibitor | 0.09 0.057 DBMET01926 0.103 0.035 DBMET01927 0.105 0.033 DBMET01928 0.085 0.067 DBMET01929 0.088 0.06 DBMET01934 0.082 0.074 DBMET01935 0.081 0.077 DBMET01937 0.093 0.051 DBMET01942 0.092 0.053 DBMET01933 0.121 0.019 DBMET01936 0.081 0.077 DBMET01940 | DBMET01936 | |
| 0.086 | 0.239 | 0.262 | Interleukin 6 antagonist | 0.194 0.044 DBMET01926 0.262 0.021 DBMET01927 0.201 0.04 DBMET01928 0.159 0.077 DBMET01929 0.193 0.045 DBMET01934 0.197 0.042 DBMET01935 0.164 0.07 DBMET01937 0.187 0.049 DBMET01942 0.132 0.121 DBMET01932 0.194 0.045 DBMET01933 0.247 0.024 DBMET01936 0.153 0.085 DBMET01938 0.134 0.116 DBMET01939 0.164 0.07 DBMET01940 0.16 0.075 DBMET01941 | DBMET01927 | |
| 0.042 | 0.199 | 0.117 | Sphingomyelinase inhibitor | 0.094 0.067 DBMET01926 0.117 0.043 DBMET01937 0.085 0.079 DBMET01942 0.095 0.066 DBMET01932 0.091 0.071 DBMET01933 0.09 0.072 DBMET01939 0.117 0.043 DBMET01940 0.098 0.061 DBMET01941 | DBMET01940 | |
| 0.079 | 0.241 | 0.138 | DNA repair enzyme inhibitor | 0.138 0.044 DBMET01928 0.111 0.094 DBMET01937 0.109 0.099 DBMET01939 0.111 0.094 DBMET01940 | DBMET01928 | |
| 0.063 | 0.228 | 0.478 | Angiogenesis stimulant | 0.416 0.019 DBMET01926 0.334 0.037 DBMET01927 0.383 0.025 DBMET01928 0.405 0.021 DBMET01929 0.367 0.028 DBMET01934 0.4 0.022 DBMET01935 0.444 0.016 DBMET01937 0.418 0.019 DBMET01942 0.28 0.057 DBMET01932 0.478 0.013 DBMET01933 0.365 0.029 DBMET01936 0.4 0.022 DBMET01938 0.429 0.018 DBMET01939 0.444 0.016 DBMET01940 0.422 0.018 DBMET01941 | DBMET01933 | |
| 0.056 | 0.234 | 0.103 | Phosphodiesterase 6D inhibitor | 0.103 0.047 DBMET01933 | DBMET01933 | |
| 0.05 | 0.231 | 0.111 | Bone formation stimulant | 0.111 0.095 DBMET01933 | DBMET01933 | |
| 0.05 | 0.232 | 0.193 | Beta amyloid protein antagonist | 0.126 0.061 DBMET01926 0.144 0.045 DBMET01935 0.125 0.063 DBMET01942 0.193 0.019 DBMET01933 | DBMET01933 | |
| 0.037 | 0.22 | 0.061 | Lipocortins synthesis agonist | 0.059 0.038 DBMET01926 0.06 0.035 DBMET01927 0.061 0.034 DBMET01928 0.058 0.039 DBMET01929 0.058 0.04 DBMET01934 0.056 0.046 DBMET01935 0.057 0.043 DBMET01937 0.058 0.04 DBMET01942 0.054 0.051 DBMET01932 0.06 0.035 DBMET01933 0.054 0.052 DBMET01936 0.056 0.045 DBMET01938 0.057 0.044 DBMET01939 0.057 0.043 DBMET01940 0.058 0.039 DBMET01941 | DBMET01928 | |
| 0.047 | 0.241 | 0.357 | Lipid peroxidase inhibitor | 0.23 0.031 DBMET01926 0.216 0.035 DBMET01927 0.203 0.04 DBMET01928 0.237 0.03 DBMET01929 0.159 0.062 DBMET01934 0.257 0.025 DBMET01935 0.225 0.033 DBMET01937 0.283 0.021 DBMET01942 0.357 0.012 DBMET01933 0.228 0.032 DBMET01936 0.246 0.028 DBMET01938 0.232 0.031 DBMET01939 0.225 0.033 DBMET01940 0.21 0.038 DBMET01941 | DBMET01933 | |
| 0.115 | 0.313 | 0.245 | Vasodilator, peripheral | 0.202 0.173 DBMET01937 0.245 0.131 DBMET01933 0.202 0.173 DBMET01940 | DBMET01933 | |
| 0.023 | 0.236 | 0.069 | Protein kinase C alpha inhibitor | 0.069 0.046 DBMET01937 0.063 0.055 DBMET01933 0.069 0.046 DBMET01940 | DBMET01940 | |
| 0.035 | 0.25 | 0.111 | Topoisomerase II inhibitor | 0.095 0.091 DBMET01927 0.105 0.081 DBMET01928 0.111 0.075 DBMET01933 | DBMET01933 | |
| 0.068 | 0.289 | 0.202 | Hypolipemic | 0.149 0.138 DBMET01926 0.183 0.107 DBMET01928 0.148 0.138 DBMET01929 0.197 0.096 DBMET01934 0.176 0.113 DBMET01937 0.148 0.138 DBMET01942 0.202 0.092 DBMET01933 0.161 0.126 DBMET01936 0.164 0.123 DBMET01938 0.174 0.115 DBMET01939 0.176 0.113 DBMET01940 0.179 0.111 DBMET01941 | DBMET01933 | |
| 0.068 | 0.294 | 0.463 | NOS3 expression enhancer | 0.352 0.011 DBMET01926 0.338 0.013 DBMET01927 0.364 0.01 DBMET01928 0.342 0.012 DBMET01929 0.347 0.012 DBMET01934 0.344 0.012 DBMET01935 0.334 0.013 DBMET01937 0.374 0.009 DBMET01942 0.235 0.03 DBMET01932 0.463 0.005 DBMET01933 0.406 0.008 DBMET01936 0.326 0.014 DBMET01938 0.326 0.014 DBMET01939 0.334 0.013 DBMET01940 0.361 0.01 DBMET01941 | DBMET01933 | |
| 0.024 | 0.254 | 0.142 | Protein kinase A inhibitor | 0.13 0.03 DBMET01926 0.097 0.047 DBMET01929 0.12 0.034 DBMET01935 0.121 0.033 DBMET01937 0.126 0.031 DBMET01942 0.138 0.028 DBMET01933 0.108 0.04 DBMET01938 0.091 0.052 DBMET01939 0.121 0.033 DBMET01940 0.142 0.027 DBMET01941 | DBMET01941 | |
| 0.068 | 0.311 | 0.542 | Free radical scavenger | 0.402 0.028 DBMET01926 0.461 0.02 DBMET01927 0.371 0.034 DBMET01928 0.406 0.028 DBMET01929 0.302 0.051 DBMET01934 0.438 0.023 DBMET01935 0.4 0.029 DBMET01937 0.474 0.019 DBMET01942 0.218 0.084 DBMET01932 0.542 0.012 DBMET01933 0.406 0.028 DBMET01936 0.429 0.024 DBMET01938 0.405 0.028 DBMET01939 0.4 0.029 DBMET01940 0.406 0.028 DBMET01941 | DBMET01933 | |
| 0.018 | 0.273 | 0.064 | Nitric oxide donor | 0.064 0.041 DBMET01933 0.064 0.042 DBMET01936 0.059 0.05 DBMET01938 0.056 0.055 DBMET01941 | DBMET01936 | |
| 0.072 | 0.332 | 0.61 | Antioxidant | 0.472 0.023 DBMET01926 0.459 0.025 DBMET01927 0.452 0.026 DBMET01928 0.498 0.02 DBMET01929 0.355 0.045 DBMET01934 0.498 0.02 DBMET01935 0.486 0.022 DBMET01937 0.534 0.017 DBMET01942 0.348 0.047 DBMET01932 0.61 0.011 DBMET01933 0.471 0.024 DBMET01936 0.526 0.017 DBMET01938 0.51 0.019 DBMET01939 0.486 0.022 DBMET01940 0.471 0.024 DBMET01941 | DBMET01933 | |
| 0.036 | 0.309 | 0.096 | Estrogen receptor beta antagonist | 0.096 0.072 DBMET01929 | DBMET01929 | |
| 0.056 | 0.331 | 0.449 | Nitric oxide antagonist | 0.373 0.029 DBMET01926 0.253 0.051 DBMET01927 0.3 0.04 DBMET01928 0.36 0.03 DBMET01929 0.259 0.049 DBMET01934 0.372 0.029 DBMET01935 0.395 0.026 DBMET01937 0.394 0.026 DBMET01942 0.235 0.056 DBMET01932 0.449 0.02 DBMET01933 0.356 0.031 DBMET01936 0.42 0.023 DBMET01938 0.381 0.028 DBMET01939 0.395 0.026 DBMET01940 0.366 0.03 DBMET01941 | DBMET01933 | |
| 0.012 | 0.291 | 0.051 | Microtubule stabilization | 0.041 0.04 DBMET01933 0.051 0.026 DBMET01936 | DBMET01936 | |
| 0.056 | 0.347 | 0.276 | Platelet adhesion inhibitor | 0.247 0.05 DBMET01926 0.179 0.083 DBMET01929 0.133 0.128 DBMET01934 0.248 0.05 DBMET01935 0.262 0.045 DBMET01937 0.257 0.047 DBMET01942 0.276 0.041 DBMET01933 0.227 0.058 DBMET01936 0.175 0.085 DBMET01938 0.195 0.074 DBMET01939 0.262 0.045 DBMET01940 0.243 0.052 DBMET01941 | DBMET01933 | |
| 0.016 | 0.311 | 0.073 | Lipase inhibitor | 0.073 0.051 DBMET01933 | DBMET01933 | |
| 0.067 | 0.362 | 0.368 | DNA damaging | 0.255 0.078 DBMET01926 0.184 0.13 DBMET01928 0.218 0.102 DBMET01929 0.243 0.084 DBMET01935 0.323 0.049 DBMET01937 0.261 0.074 DBMET01942 0.368 0.036 DBMET01933 0.169 0.146 DBMET01936 0.354 0.04 DBMET01938 0.28 0.066 DBMET01939 0.323 0.049 DBMET01940 0.223 0.098 DBMET01941 | DBMET01933 | |
| 0.08 | 0.383 | 0.327 | Angiogenesis inhibitor | 0.22 0.148 DBMET01926 0.244 0.127 DBMET01928 0.315 0.085 DBMET01929 0.243 0.129 DBMET01935 0.208 0.16 DBMET01937 0.224 0.144 DBMET01942 0.206 0.163 DBMET01932 0.316 0.085 DBMET01933 0.327 0.08 DBMET01936 0.322 0.082 DBMET01938 0.296 0.095 DBMET01939 0.208 0.16 DBMET01940 0.203 0.167 DBMET01941 | DBMET01936 | |
| 0.042 | 0.348 | 0.112 | Estrogen antagonist | 0.112 0.071 DBMET01929 0.107 0.082 DBMET01933 0.105 0.087 DBMET01939 | DBMET01929 | |
| 0.008 | 0.317 | 0.443 | Antineoplastic antibiotic | 0.093 0.049 DBMET01926 0.101 0.046 DBMET01927 0.132 0.035 DBMET01928 0.13 0.036 DBMET01929 0.11 0.042 DBMET01934 0.093 0.049 DBMET01935 0.099 0.047 DBMET01937 0.1 0.046 DBMET01942 0.443 0.005 DBMET01932 0.126 0.037 DBMET01933 0.165 0.028 DBMET01936 0.123 0.038 DBMET01938 0.136 0.034 DBMET01939 0.099 0.047 DBMET01940 0.088 0.052 DBMET01941 | DBMET01932 | |
| 0.115 | 0.432 | 0.687 | Apoptosis agonist | 0.613 0.046 DBMET01926 0.566 0.057 DBMET01927 0.589 0.052 DBMET01928 0.672 0.035 DBMET01929 0.47 0.084 DBMET01934 0.603 0.048 DBMET01935 0.592 0.051 DBMET01937 0.632 0.043 DBMET01942 0.528 0.066 DBMET01932 0.686 0.033 DBMET01933 0.593 0.051 DBMET01936 0.687 0.033 DBMET01938 0.651 0.039 DBMET01939 0.592 0.051 DBMET01940 0.578 0.054 DBMET01941 | DBMET01938 | |
| 0.013 | 0.335 | 0.085 | Protein 50S ribosomal subunit inhibitor | 0.059 0.031 DBMET01926 0.063 0.029 DBMET01927 0.069 0.025 DBMET01928 0.061 0.03 DBMET01929 0.068 0.025 DBMET01934 0.052 0.038 DBMET01935 0.055 0.035 DBMET01937 0.054 0.036 DBMET01942 0.054 0.036 DBMET01932 0.06 0.031 DBMET01933 0.085 0.017 DBMET01936 0.056 0.034 DBMET01938 0.056 0.034 DBMET01939 0.055 0.035 DBMET01940 0.057 0.033 DBMET01941 | DBMET01936 | |
| 0.085 | 0.485 | 0.389 | Caspase 3 stimulant | 0.283 0.088 DBMET01926 0.223 0.139 DBMET01927 0.256 0.107 DBMET01929 0.304 0.077 DBMET01935 0.31 0.074 DBMET01937 0.324 0.068 DBMET01942 0.329 0.066 DBMET01933 0.389 0.048 DBMET01938 0.279 0.09 DBMET01939 0.31 0.074 DBMET01940 0.268 0.098 DBMET01941 | DBMET01938 | |
| 0.024 | 0.428 | 0.112 | Neurotrophic factor | 0.112 0.109 DBMET01938 | DBMET01938 | |
| 0.042 | 0.447 | 0.221 | P-glycoprotein inhibitor | 0.138 0.136 DBMET01933 0.221 0.052 DBMET01936 | DBMET01936 | |
| 0.013 | 0.443 | 0.059 | Antibiotic Aminoglycoside-like | 0.051 0.013 DBMET01926 0.056 0.01 DBMET01927 0.056 0.01 DBMET01928 0.05 0.013 DBMET01929 0.059 0.009 DBMET01934 0.047 0.015 DBMET01935 0.055 0.01 DBMET01937 0.047 0.015 DBMET01942 0.047 0.015 DBMET01932 0.052 0.012 DBMET01933 0.058 0.009 DBMET01936 0.052 0.012 DBMET01938 0.054 0.011 DBMET01939 0.055 0.01 DBMET01940 0.051 0.013 DBMET01941 | DBMET01934 | |
| 0.011 | 0.478 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET01934 | DBMET01934 | |
| 0.029 | 0.5 | 0.133 | Amyloid beta aggregation inhibitor | 0.133 0.123 DBMET01933 | DBMET01933 | |
| 0.015 | 0.524 | 0.122 | Histone deacetylase SIRT1 stimulant | 0.081 0.042 DBMET01926 0.082 0.042 DBMET01927 0.081 0.043 DBMET01928 0.073 0.051 DBMET01929 0.088 0.037 DBMET01935 0.09 0.035 DBMET01937 0.098 0.029 DBMET01942 0.122 0.017 DBMET01933 0.091 0.034 DBMET01938 0.081 0.042 DBMET01939 0.09 0.035 DBMET01940 0.083 0.041 DBMET01941 | DBMET01933 | |
| 0.015 | 0.524 | 0.122 | Histone deacetylase stimulant | 0.081 0.042 DBMET01926 0.082 0.042 DBMET01927 0.081 0.043 DBMET01928 0.073 0.051 DBMET01929 0.088 0.037 DBMET01935 0.09 0.035 DBMET01937 0.098 0.029 DBMET01942 0.122 0.017 DBMET01933 0.091 0.034 DBMET01938 0.081 0.042 DBMET01939 0.09 0.035 DBMET01940 0.083 0.041 DBMET01941 | DBMET01933 | |
| 0.031 | 0.552 | 0.433 | Tumour necrosis factor alpha release inhibitor | 0.343 0.04 DBMET01926 0.212 0.099 DBMET01927 0.205 0.105 DBMET01928 0.298 0.054 DBMET01929 0.173 0.132 DBMET01934 0.28 0.062 DBMET01935 0.342 0.04 DBMET01937 0.349 0.038 DBMET01942 0.179 0.127 DBMET01932 0.433 0.022 DBMET01933 0.225 0.089 DBMET01936 0.336 0.042 DBMET01938 0.299 0.053 DBMET01939 0.342 0.04 DBMET01940 0.324 0.045 DBMET01941 | DBMET01933 | |
| 0.014 | 0.535 | 0.124 | Protein kinase C mu inhibitor | 0.094 0.063 DBMET01926 0.088 0.07 DBMET01935 0.081 0.08 DBMET01937 0.088 0.07 DBMET01942 0.092 0.065 DBMET01932 0.123 0.04 DBMET01933 0.124 0.039 DBMET01938 0.081 0.08 DBMET01940 0.086 0.072 DBMET01941 | DBMET01938 | |
| 0.005 | 0.541 | 0.026 | Protein 30S ribosomal subunit inhibitor | 0.026 0.015 DBMET01927 0.021 0.02 DBMET01928 0.023 0.018 DBMET01934 0.021 0.02 DBMET01937 0.022 0.02 DBMET01933 0.024 0.016 DBMET01936 0.022 0.019 DBMET01938 0.022 0.02 DBMET01939 0.021 0.02 DBMET01940 | DBMET01927 | |
| 0.011 | 0.563 | 0.143 | Topoisomerase I inhibitor | 0.093 0.076 DBMET01929 0.087 0.082 DBMET01935 0.13 0.05 DBMET01937 0.108 0.063 DBMET01942 0.143 0.044 DBMET01933 0.101 0.069 DBMET01938 0.141 0.045 DBMET01939 0.13 0.05 DBMET01940 0.089 0.08 DBMET01941 | DBMET01933 | |
| 0.042 | 0.628 | 0.35 | Immunomodulator | 0.252 0.113 DBMET01926 0.339 0.064 DBMET01927 0.312 0.076 DBMET01928 0.288 0.089 DBMET01929 0.256 0.11 DBMET01934 0.228 0.134 DBMET01935 0.317 0.073 DBMET01937 0.209 0.153 DBMET01942 0.26 0.107 DBMET01933 0.296 0.084 DBMET01936 0.244 0.12 DBMET01938 0.35 0.06 DBMET01939 0.317 0.073 DBMET01940 0.266 0.103 DBMET01941 | DBMET01939 | |
| 0.018 | 0.656 | 0.235 | Vasodilator | 0.173 0.129 DBMET01937 0.168 0.134 DBMET01942 0.235 0.078 DBMET01933 0.169 0.133 DBMET01939 0.173 0.129 DBMET01940 | DBMET01933 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |